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List of abbreviations 
 
5-HT   Serotonin  
AA   Ascorbic acid 
AAO   Aromatic alcohol oxidase 
ADH    Alcohol dehydrogenase 
ALDH  Aldehyde dehydrogenase 
AMPA α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid 
AOx   Alcohol oxidase 
AUX   Auxiliary electrode  
BALs   Blood alcohol levels  
BSA    Bovine serum albumin 
cAMP   Cyclic adenosine monophosphate 
CNS   Central nervous system 
CoA   Coenzyme A 
CPA    Constant potential amperometry 
CV    Cyclic voltammetry  
DA   Dopamine  
DAT   Dopamine transporter  
EC(number) Enzyme Commission number  
EtOH   Ethanol 
FAD    Flavin adenine dinucleotide 
FAS    Fetal alcohol syndrome  
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GA   Glutaraldehyde  
GABA   γ-Aminobutyric acid 
H2O2   Hydrogen peroxide  
HPLC  High performance liquid chromatography 
LCAO   Long-chain alcohol oxidase 
LOD    Limit of detection 
LOQ   Limit of quantification  
LRS   Linear region slope 
MAPK  Mitogen-activated protein kinase 
MCU   Microcontroller unit  
MEOS   Microsomial ethanol oxidizing system 
MRI   Magnetic resonance imaging 
MRS   Magnetic resonance spectroscopy  
NAChRs  Nicotinic acetylcholine receptors  
NAD+   Nicotinamide adenine dinucleotide  
NADH  Nicotinamide adenine dinucleotide hydrogen 
NADP   Nicotinamide adenine dinucleotide phosphate 
NADPH  Nicotinamide adenine dinucleotide phosphate 
hydrogen 
NMDA  N-Methyl-D-aspartate 
NMR   Nuclear magnetic resonance  
OPA    Operational amplifier  
oPD   ortho-Phenylenediamine 
PBS    Phosphate buffered saline 
PEI    Polyethyleinimine  
PET   Positron emission tomography  
PPD   Poly-ortho-phenylenediamine  
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ppm    Parts per million  
Pt   Platinum  
PU    Polyurethane 
RE   Reference electrode  
SAO   Secondary alcohol oxidase  
SCAO  Short-chain alcohol oxidase 
THF   Tetrahydrofuran 
VTA   Ventral tegmental area  
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1.1 Ethanol  
 
Ethanol (EtOH) is the main non-aqueous component of alcoholic drinks: wine, beer, 
liquor spirits, etc. all contain this molecule, and are therefore referred to generically 
as “alcohol”. Thus, ethanol and alcohol will be used with the same meaning in this 
dissertation. Alcoholic beverages have been strongly associated with human society 
since the early stages of civilization. Nowadays, the consumption of EtOH is a legal, 
commonly-accepted and widespread practice in nearly all societies, particularly in 




Figure 1: The ethanol molecule: planar and 3D representations  
 
The chemical nomenclature of ethanol, appearing as a transparent liquid, is ethyl 
alcohol, a small organic amphiphilic molecule with formula CH3CH2OH and 
molecular weight of 46.07 g/mol (Figure 1). It is composed of a short two-carbon 
aliphatic chain and an hydroxyl group, which confer on the molecule both 
hydrophilic and lipophilic properties. This amphiphilic characteristic is critical for its 
biological activity, allowing alcohol to pass through biological membranes as well as 
to dissolve in blood and extracellular fluids. 
When orally ingested, alcohol is absorbed by the digestive system and delivered by 
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Ethanol soon interacts with human body in various ways, producing a magnitude of 
effects depending on the intake level. It has been demonstrated that a low regular 
moderate consumption of alcohol may have positive effects; in particular, red wine 
contains some antioxidant molecules (mainly resveratrol) helpful to the heart, and 
may facilitate the early outcome after acute infarct and diminish the risk of cardiac 
death (Carrizzo et al., 2013; Tung et al., 2013). 
Moreover, an unregulated use of alcohol is truly unsafe, due to its toxic action on 
organs (chiefly the liver), the teratogenic properties and its psychoactive effects. A 
clear example of the consequences of excessive alcohol consumption is represented 
by the elevated number of victims from road accidents: high levels of ethanol found 
in drivers’ blood is the major cause of death from car crashes, especially among 
young drivers. In order to discourage the driving of vehicles under the influence of 
alcohol and reduce the cases of death, several laws have been adopted in recent years 
in many countries (Voas et al., 2013; Voas and Fell, 2013). 
When high doses of ethanol are chronically assumed, psychophysical damage 
happens. An individual who loses control over alcohol use, becoming unable to drink 
responsibly, could develop a severe disorder called alcoholism, a progressive disease 
causing peripheral organ and brain damage, and contributing to the deterioration of 
cognitive functions. Alcoholism is considered the main cause of dementia (Oslin et 
al., 1998) and affects the ability to decide correctly and to feel emotions 
(Pfefferbaum et al., 1998). This underestimated disease represents a plague for the 
society, because of the medical and social impacts and the health-care costs (Mokdad 
et al., 2004; Hasin et al., 2007). Ethanol abuse compromises the physiological 
function of several organs and systems: the liver is particularly involved, alcohol 
being able to induce cirrhosis and steatosis (Fickert and Zatloukal, 2000); pancreas 
and the entire digestive system are also affected (Seitz et al., 1994), as well as 
skeletal muscle (Panzak et al., 1998), hematopoiesis (Wartenberg, 1998), the 
cardiovascular system, body temperature (Hardman and Limbird, 2005), the 
endocrine system (Noth and Walter, 1984), and the nervous system (Charness et al., 
1989). Moreover, alcohol passes through the placental barrier and inhibits fetal 
growth or weight, creating typical facial stigmata and a series of mental and physical 
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damage, producing the so-called fetal alcohol syndrome or FAS (Lemoine et al., 
2003). 
So, although alcohol drinking has been common in human culture since the 
beginning of recorded history for hygienic, dietary, medicinal, and religious reasons, 
as well for recreational purposes, the above discussed negative aspects related to its 
uncontrolled assumption make it a dangerous drug for human health. 
Compared with other kinds of abuse substances, larger amounts of alcohol are 
required to elicit the toxicological effects, resulting in its intake more as a food than a 
drug in non-heavy drinkers. Anyhow, alcohol is the most consumed psychoactive 
drug due to its abilities to change human consciousness and to its easy availability. It 
acts mainly as a depressant substance while its effects depend on the intake (the term 
depressant means that EtOH weakens brain function, and not that is able to induce 
depression as a disease). 
Ethanol pharmacokinetic profiles of absorption, distribution and elimination 
determine the level of systemic exposure to ethanol. In fact, ethanol blood levels are 
linked with the amount assumed, which can be expressed as alcoholic units. An 
alcohol unit is equal to 12 grams (0.26 mol), corresponding to standard volumes of 
beer (330 mL, 4.5°), wine (125 mL, 12°) and hard alcoholic drinks (40 mL, 40°). Not 
surprisingly, the more alcohol is assumed, the higher will be its blood concentration. 
The intake is then distributed to all body fluids, so ethanol blood levels are also the 
result of its dilution. 
 
When small amounts of ethanol (2–20 mM) arrive to the central nervous system 
(CNS), a lack of inhibition and euphoric behaviors appear. Higher concentrations 
lead to psychoactive effects, such as anxiety reduction. Gradual increases (21–86 
mM) lead to several and progressive changes in its effects: behavior can turn from 
being expansive and vivacious to uncontrolled mood swings and emotional reactions, 
that could even possess a violent component. During acute intoxication, an increase 
in reaction time clearly appears, coupled with a decrease of motor control and 
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 Moreover, symptoms of severe intoxication (about 65 mM) are vomiting, a 
condition of general anesthesia and brain-impaired functionality. Coma and lethal 
effects following an acute very high intoxication (86–100 mM) are mainly related to 
respiratory depression (Schuckit, 1995). 
Even if alcohol is commonly consumed among people of most populations, not 
everybody who experiences alcohol develops an addiction. Recent studies have 
revealed how genetic differences are critical for individual and racial variations of 
EtOH effects. Indeed, for acute or chronic exposure, susceptibility to alcohol-related 
diseases are linked to heterogeneity in alcohol metabolism and of its first metabolite, 
acetaldehyde (Meier-Tackmann et al., 1990; Eckey et al., 1990).  
 
The reasons of the transition from regular alcohol consumption to alcohol addiction 
development could be the consequence of several factors, still not fully understood. 
However, as argued below (Sections 1.3.7 and 1.4), impairment of the 
mesocorticolimbic dopaminergic system and the resulting increase of alcohol 
consumption seem to fit a possible explanation (Munson et al., 1995). 
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1.2 Ethanol pharmacokinetics 
 
A brief summary of ethanol pharmacokinetics is discussed to describe how this 
molecule is absorbed, distributed, metabolized and eliminated in humans, and how 
these processes could be affected by the co-assumption of other drugs. 
 
The pharmacokinetics of ethanol orally ingested starts when it reaches the 
gastrointestinal system. In this site it is absorbed into the bloodstream and then 
distributes to all the tissues and fluids. The relative water content of a tissue 
determines the equilibrium concentration of ethanol. Three important factors 
influence the rate of equilibration of ethanol within a tissue: its water content, its 
mass and the rate of local blood flow (Hardman and Limbird, 2005). 
Ethanol absorption starts in the stomach (20%), where, exploiting its amphiphilicity, 
it diffuses across cells that line the gastric wall. The main site of its absorption occurs 
when it passes into the small intestine (80%) as the characteristics of the duodenum 
and jejunum walls make absorption much more rapid than from the stomach. 
The rate of alcohol passage into the circulatory system is affected by several aspects, 
such as the rate of ingestion or the presence of food in the stomach. Food, 
particularly fatty foods, slows the absorption process, while carbonated drinks 
accelerate the passage of ethanol trough the gastric wall. When the stomach is empty, 
the ethanol hematic peak is reached about 30 minutes after its intake. 
Through the enterohepatic circulation, ethanol reaches the liver where several 
enzymatic systems transform it into its metabolites. The first-pass effect, which 
reduces blood alcohol levels (BALs), is chiefly exerted by the hepatic organ but 
starts in the stomach, where the enzyme alcohol dehydrogenase (ADH) converts 
ethanol into acetaldehyde. Gastric ADH is not homogeneously expressed in men and 
women; females have less enzyme present in the stomach wall; so, ethanol 
bioavailability is higher, leading to generally higher BALs in women (Hardman and 
Limbird, 2005).  
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Additional, but tiny, amounts of ethanol are transformed by mean of non-oxidative 
reactions in the kidneys and lungs, or excreted unmodified in urine, sweat, and breath 
(Hardman and Limbird, 2005).  
Alcohol eliminated by the lungs is readily detectable in expired air. The common 
ratio between blood:expired air ethanol is about 2100:1. Thus, by quantifying its 
concentration in the breath, it is possible to calculate alcohol blood levels (Holford, 
1987). Common breathalyzer tests work by estimating ethanol breath concentrations.  
 
The largest part of ethanol intake, corresponding to about 80-90%, is metabolized in 
the liver by means of hepatic oxidation. In the hepatocytes, different systems 
contribute to exert the first-passage effect and to convert alcohol into its metabolites.  
The major pathway present in liver parenchymal cells (Figure 2, panel A) uses two 
sequential oxidative reactions, involving the cytosolic enzyme ADH and aldehyde 
dehydrogenase (ALDH), both located in hepatocytes cytosol and mitochondria 
(Crow, 1985; Hardman and Limbird, 2005). The first reaction converts ethanol into 
acetaldehyde, which is then further oxidized to acetic acid by ALDH. Both reactions 
require the presence of NAD+  as cofactor (Nicotinamide adenine dinucleotide), 
which is converted to its reduced form NADH. The ethanol-derived acetate is linked 
by coenzyme A, forming acetyl CoA that reaches the pathway of the Kreb cycle or is 
used to form fatty acids or ketone bodies.  
The rate of ethanol metabolism performed by this pathway is limited by the 
maximum capacity of ADH (Blomstrand and Theorell, 1970; Salaspuro et al., 1977). 
The rate of the reaction is also affected by NAD+ availability. Drinking high amount 
of ethanol causes an increase in the hepatic NADH:NAD+ ratio. As a consequence, 
NADH is accumulated into cytosolic and mitochondrial compartments, so other 
enzymes requiring NAD+ are inhibited. When this happens, lactate accumulates, 
NADH and acetyl CoA levels increase, leading to acidosis and fatty acid synthesis. 
Also, oxidation of fatty acids is compromised by the excess of H+ derived from the 
conversion of NAD+ into NADH, which is used by mitochondria instead of H+ 
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In this way, fatty acid accumulates in the hepatocytes, leading to steatosis and others 
alcohol-related hepatic diseases (Blomstrand and Theorell, 1970). 
 
 
Figure 2: Scheme of Ethanol metabolism 
A second pathway (Figure 2, panel B) responsible for hepatic alcohol oxidation is 
represented by the microsomal ethanol oxidizing system (MEOS). It involves 
NADPH (Nicotinamide adenine dinucleotide phosphate hydrogen) as cofactor, and, 
using molecular oxygen, transforms ethanol into acetaldehyde and water as 
byproduct. Acetaldehyde is then oxidized by ALDH. MEOS is an inducible system, 
the whole activity, and particularly that of the cytochrome P450, is increased by 
continual exposure to ethanol, regulating its activity in regard to the need. Heavy 
drinkers have 2–3 higher levels of microsomal enzymes (Grunnet et al., 1973).  
When MEOS is over stimulated, in conjunctions with an absence of adequate 
antioxidant concentration, free radicals are generated and accumulate in the 
hepatocytes. The production of hydrogen peroxide (H2O2) and oxygen radicals 
enhances oxidative stress, damaging the hepatic cells by affecting biological 
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A small part of ethanol is converted into acetaldehyde by a minor pathway which 
plays a marginal role. It involves peroxisomes, specialized small cell organelles, 
using the oxidizing enzyme catalase to metabolize alcohol with H2O2 (Figure 2, 
panel C). H2O2 availability is usually low in the liver, so this pathway does not 
significantly support ethanol metabolism (Crow, 1985).  
 
Only for very low concentrations of EtOH does the rate of alcohol elimination follow 
first-order kinetics, and linearity is observed since ADH is no longer saturated with 
ethanol. For higher concentrations, EtOH elimination follows Michaelis–Menten 
kinetics. For very high concentrations, alcohol elimination is defined as zero-order 
kinetics because the rate becomes independent of the alcohol blood concentration. 
(Holford, 1987; Adams, 1988). 
 
BALs reached in individuals are generally strictly connected with body weight and 
with total body water amount. Because generally women are smaller than men, body 
water per unit weight is less and EtOH is distributed in a smaller volume. Together 
with difference in gastric ADH expression, this is the other main reason of higher 
BALs found in women with respect to men (Niaura et al., 1987).  
 
Individuals show a great variation in the proportion of fat and water in their bodies. 
Due also to the low lipid:water partition coefficient of ethanol (Niaura et al., 1987) 
the same intake of alcohol per unit body weight can lead to very different BALs. The 
ratio between total body mass and total body water changes when people age. In 
particular, lean body mass diminishes and adipose tissue increases, so the volume of 
total body water decreases. This trend also displays a gender difference: aging from 
25 to 60 years leads men to double the fat portion of the total body mass, while in 
women is increased by only 50%. Given that, because alcohol concentrates more into 
the body fluids, it is prudent to limit ethanol assumption to only one alcoholic unit 
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Nevertheless, there are many other differences affecting alcohol metabolism 
depending on gender, ethnicity, age, genetics, enzymatic variations, liver efficiency, 
the presence of relevant co-morbidities, as well as the co-administration of drugs that 
interact with alcohol (Vestal et al., 1977). For example, it appears that some 
individual and inter-ethnic variability is due to allelic variants in genes coding for the 
enzymes involved in the major metabolic pathway: ADH and ALDH (Inoue et al., 
1984). Alcohol dehydrogenase is an oxidoreductase enzyme. It is a dimeric zinc-
containing protein, tasked to oxidize the small part of endogenous ethanol produced 
by microorganisms in the intestine, and mainly to oxidize alcohols introduced with 
the diet. It is an aspecific enzyme, able to metabolize primary and secondary short 
chain alcohols such as methanol, ethanol or other exogenous alcohols, using NAD+ 
as cofactor. Five ADH classes have been recognized based on the structure of the 
two subunits and kinetic characteristics, and further subdivided into subclasses 
according to their alleles composition.  
 
The class I ADH isoforms play the chiefly role in ethanol oxidation. The variability 
in efficiency for metabolizing ethanol showed by human populations seems to be 
related with ability to form many isoforms, with varying kinetic properties (Edenberg 
et al., 1999). Populations expressing genotypes ADH2*1 and ADH3*1 are subjected 
to an increased risk of developing alcoholism, due to the higher efficiency in alcohol 
metabolism of those enzymes (Lee et al., 2004) 
 
Aldehyde dehydrogenase also has been well studied. Nine different families of 
ALDH has been identified, but seems that only isoform 1 and 2 are involved in 
acetaldehyde metabolism (Agarwal, 2001). Several studies has shown how ALDH2 
is genetically involved in alcoholism. This isoform is present in humans with four 
different allelic variants (Crabb et al., 1993). Variant 2 has a low catalytic activity, 
and seems to have a protective role against alcoholism because it leads to the 
accumulation of acetaldehyde, resulting in rapid appearance of severe adverse 
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ALDH2, variant 2, has been found in 50% of Asian people, and discourages those 
from becoming hard drinkers (McCarver et al., 1997; Li, 2000). 
Moreover, genetic variations explain a direct correlation between genes and 
alcoholism in human. Studies conducted on twins and adopted children has revealed 
how alcohol addiction is related to genetic variations, as well as to environmental 
variations, for between 40 and 60% of cases (Begleiter and Kissin, 1995). 
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1.2.1 Ethanol and drugs interaction 
 
Drinking alcoholic beverages while consuming drugs could affect the 
pharmacodynamic and pharmacokinetic effects of both. Alteration of ethanol 
bioavailability, as well as of the drugs, is a potential hazard of intoxication and 
adverse effects. A very high percentage of adults use prescription medications. Many 
of these, as well as herbal medicines and illegal drugs are known to interact with 
alcohol, increasing the risk of illness, injury, or death. 
 
It is difficult to predict what could happen when an individual consumes both alcohol 
and medication, and the more drugs taken, the harder to estimate the effects on the 
user. Patients who assume a large number of drugs deserve special attention because 
of the increased risk and severity of potential drug–alcohol interactions (Nolan et al., 
1988). 
 
Ethanol and drugs could interact in several ways (Saunders, 1986). When certain 
medications and alcohol compete in the body for absorption, the potency of the 
medication and/or alcohol is often increased. An acute dose of alcohol may inhibit a 
drug’s metabolism by competing for the same or similar metabolizing enzymes. This 
could increase the risk of adverse side effects, because the prolonged interaction 
could enhance the drug’s availability. 
 
Furthermore, as mentioned above (Section 1.2), a chronic intake of alcohol may 
activate hepatic drug-metabolizing enzymes, such as the inductive systems of 
MEOS, chiefly cytochrome P450. If the drug is metabolized by that system, an 
increase in number of enzyme molecules reduces the drug’s availability leading to 
diminished drug efficacy. In addition, enzymes activated by long-term alcohol 
consumption may transform some drugs into toxic chemicals able to damage the 





Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
A range of drugs are known to interact with alcoholic beverages. Aspirin, for 
example, enhances ethanol bioavailability by inhibiting gastric ADH. Simultaneous 
assumption of aspirin and alcohol can increase gastrointestinal blood loss and 
damage the mucosal lining of the stomach (Risto Roine et al., 1990). ADH is also 
inhibited by 4-methylpyrazole (Blomstrand and Theorell, 1970; Salaspuro et al., 
1977), isobutyramide, and by drugs acting as histamine H2 receptor blockers such as 
cimetidine or ranitidine (Di Padova et al., 1992). 
 
As discussed later (Sections 4.7 and 5.6), ranitidine, a competitive histamine H2 
receptor antagonist widely used in peptic ulcer disease treatment (El-Bakary et al., 
2010) was found to affect ethanol metabolism by inhibiting the cytochrome P450 
(CYP2E1), alcohol dehydrogenase and aldehyde dehydrogenase enzymes, increasing 
ethanol bioavailability (Arora et al., 2000). 
 
Moreover, interaction between ethanol and drugs such as antibiotics, cardiovascular 
medications, and antidiabetic medications can reduce drug effectiveness, and 
provoke nausea, headache and other more severe adverse effects.  
 
Alcohol can also enhance the inhibitory effects of sedative and narcotic drugs at their 
site of action in the brain. Alcohol increases the rate of absorption of 
benzodiazepines and can intensify its depressant effects on the CNS (Sellers and 
Busto, 1982). Even more dangerous is the mix of ethanol and opiates (morphine, 
heroin, codeine or methadone), as well as with barbiturates (Stead and Moffat, 1983; 
Harris and Schroeder, 1982). Acting of the same neurotransmitter system, mainly 
GABA, can lead to a reduction in the level of consciousness and to a severe CNS 
depression, followed by suppression of vital functions such as respiration. The risk of 
overdose is very high. Other lethal effects can arise following depression of cardiac 
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Cannabis, used in combination with alcohol can decrease wakefulness, motor and 
intellectual abilities, and cause hallucinogenic effects (Ashton, 2001). This practice is 
currently very widespread in western societies, mostly among younger people 
(Julien, 1993).  
 
Ethanol can also counteract the effect of stimulant drugs, such as amphetamine and 
cocaine. Thus, the number of alcoholic drinks required to feel euphoric effects is 
greatly increased, leading to a false sense of sobriety.  
Then, in contrast, a negative effect called ‘coming down’, characterized by anxiety 
and depression, prevails (Burrows et al., 1993). Alcohol also increases the sedative 
effect of tricyclic antidepressants, impairing driving ability (Watson et al., 1980). 
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1.3 Ethanol pharmacodynamics 
 
Ethanol crosses the blood–brain barrier and acts as a psychoactive drug primarily 
affecting brain functions altering perception, mood, consciousness, cognition, and 
behavior. Ethanol exerts a biphasic effect on the CNS, inducing prevalently euphoric 
effects at low doses, while depressing its function when BALs increase. 
Alcohol affects the physiological action of a range of brain neurotransmitters and 
signaling molecules, such as GABA (γ-aminobutyric acid), glutamate, serotonin, 
acetylcholine, dopamine, norepinephrine, endorphin, encephalin and neuropeptide Y. 
Proteins, as molecular receptors, represent the primary sites of action for ethanol 
(Hardman and Limbird, 2005). Alcohol is able to reversibly reduce sodium transport 
in neurotransmission (Israel and Kalant, 1963), interacts with protein kinase C 
(Harris et al., 1995) and the intracellular signal-transduction cascades of MAPK 
protein (mitogen-activated protein kinase), tyrosine kinases, and also neurotrophic-
factor receptors (Valenzuela and Harris, 1997). Several ion channel types in the brain 
are sensitive to ethanol, such as voltage-gated ion channels, as well as G protein-
coupled and the ligand-gated receptor families. The effects of alcohol on the various 
neurotransmitter systems differ with acute or chronic consumption. A summary of 
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1.3.1 Ethanol and GABA 
 
GABA is the principal mediator of inhibitory neurotransmission in the brain. Located 
both on pre- and postsynaptic neurons, GABA receptors are divided into two classes 
based on their structure. GABA-B receptors are G protein-coupled metabotropic 
receptors that regulate ion channel activation, using G proteins as the signal 
mechanism. 
GABA-A receptors (Figure 3) are ionotropic receptors. Physiologically, GABA 
interacting with the ligand-gated GABA-A receptors triggers the opening of chloride 
ion channels allowing the chloride ions to flow across the membrane of the cell from 
the extracellular fluid (high Cl– levels) into the cytoplasm (low Cl– levels). The 
negative charge thus transferred into the cell causes hyperpolarization of the 
transmembrane potential (Siegel et al., 1999). 
Consistent data have emerged from biochemical, electrophysiological, and 
behavioral studies indicating that the GABA-A receptor mediates some of in-vivo 
actions of ethanol by means of binding with a specific site (Figure 3).  
 
 
Figure 3: The GABA-A receptor 
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Through a positive allosteric modulation of its receptor, acute ethanol enhances the 
effects of this inhibitory neurotransmitter (Santhakumar et al., 2007). The interaction 
between ethanol and GABAergic systems, combined with its effect on 
catecholaminergic pathways, is thought to be responsible for the motor impairment 
associated with alcohol intake (Kiianmaa, 1990). 
 
GABAergic neurotransmission is also facilitated by several others exogenous 
molecules known as GABA analogues or GABAergic drugs. GABA-A receptors are 
the target of a number of classes of sedatives, hypnotics, barbiturates, 
benzodiazepines, and volatile anesthetics. The protein in fact contains different 
allosteric binding sites for these molecules, which indirectly modulate the activity of 
the receptor. If more than one drug bind simultaneously to their respective sites, the 
opening of the ion channel can be significantly facilitated because of the summation 
of stimulations. The risk of respiratory depression is therefore increased in the 
presence of co-administration or co-abuse of these drugs (Siegel et al., 1999). 
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1.3.2 Ethanol and Glutamate  
 
Ethanol is also known to interact with receptors that mediate the excitatory 
transmission systems in the CNS. Glutamate is a non-essential amino acid precursor 
for GABA and represents the main brain excitatory neurotransmitter (De Witte, 
2004). Moreover, it plays a pivotal physiological role in memory formation, learning 
and regulation, and in pathological processes such as epileptiform seizures and 
neurotoxicity. It interacts with its receptors in the glutamatergic synapses, being 
responsible for the glutamate-mediated postsynaptic excitation of neurons (Gonzales 
and Jaworski, 1997).  
Glutamate receptors in the CN- are divided two groups, ionotropic (NMDA, kainate, 
and AMPA) and metabotropic receptors. The nomenclature of the different 
ionotropic glutamate receptors derives from the names of several compounds found 
to interact with these in the first characterization studies.  
 
- NMDA receptor, at which N-methyl-D-aspartate acts as a specific agonist. 
- AMPA receptor, able to bind α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid, an artificial glutamate analog. 
- Kainate receptor, at which kainic acid mimics the effect of glutamate. 
NMDA receptors have a voltage dependent activity and an ion channel blockable by 
extracellular Mg2+. When the receptor is activated by binding with glutamate, the 
block is removed and Ca2+ ions flow across the pore, generating an excitatory 
postsynaptic current. 
 
It has been demonstrated that acute ethanol is able to interact with glutamatergic 
neurotransmission (De Witte, 2004). Alcohol has not a specific binding site in 
glutamatergic receptors, as is the case for GABA-A, but its interaction with NMDA- 
and kainate-receptor function leads to their inhibition, while AMPA receptors seem 
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The acute ethanol-derived increase of GABAergic transmission, together with the 
disruption of the glutamatergic tone in the CNS are responsible for the euphoric, 
sedative, tranquilizing and anesthetic properties of beverage alcohol at low–medium 
concentrations (Lovinger et al., 1989). The dual effect of alcohol manifests when 
BALs increase further. The alteration of the glutamate system is responsible for 
staggering, slurred speech, and memory blackouts, while the further contribution of 
GABA effects, related to high ethanol doses, leads to a severe depressant effect on 
brain functionality, which in extreme cases can lead to loss of consciousness, coma 
and even death as a result of respiratory depression (De Witte, 2004). 
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1.3.3 Ethanol and Norepinephrine 
 
The euphoric and stimulant effects of low ethanol doses in the brain are also related 
to a marked increase in noradrenalin (norepinephrine) release. Several studies 
indicate that, during a drinking session, norepinephrine metabolism in the human 
CNS is stimulated, maybe by increasing the firing of central noradrenergic neurons 
(Borg et al., 1981) and that acute ethanol exposure increases norepinephrine turnover 
both centrally and peripherally by increasing spontaneous norepinephrine release 
(Degani et al., 1979). Prefrontal norepinephrine transmission seems to be a critical 
factor in the rewarding and reinforcing effects of ethanol as discussed in Section 
1.3.4 (Ventura et al., 2006). 
31 
 
Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
1.3.4 Ethanol and Acetylcholine  
 
Acetylcholine is a neurotransmitter that displays a variety of actions in both the 
peripheral and central nervous systems. Muscarinic and nicotinic are the two 
principal types of cholinergic receptors. Nicotinic acetylcholine receptors (nAChRs) 
are transmembrane receptors particularly responsive to nicotine and whose main 
physiological ligand is the neurotransmitter acetylcholine. It has emerged that 
nicotinic acetylcholine receptors sited in the CNS are target sites for ethanol, 
increasing the function of some nAChR subtypes and inhibiting the activity of others 
(Narahashi et al., 1999). Both human and animal models suggest that nicotinic 
receptors may be involved in the acute response to ethanol and in mediation of brain 
alcohol effects (Kamens and Phillips. 2008). Nicotinic acetylcholine receptors are 
involved in the acute locomotor responses that appear during a drinking session 
(Blomqvist et al.,1992; Larsson et al., 2002). Because nAChR are activated by 
nicotine, alcoholism and tobacco addiction often co-occur, although the biological 
factors that regulate the contemporary and addictive consumption of nicotine and 
alcohol in smokers and drinkers still remain unclear (DiFranza and Guerrera, 1990). 
32 
 
Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
1.3.5 Ethanol and Serotonin 
 
Serotonin (5-hydroxytryptamine, 5-HT) actions have been related to acute alcohol 
effects on the brain as well as to alcohol addiction. This monoamine is produced and 
released in the brain by specific neuronal population, especially in a cerebral areas 
called the raphe nuclei (Berger et al., 2009). 5-HT-releasing terminals from the raphe 
nuclei innervate a wide variety of forebrain regions, including the amygdala and 
nucleus accumbens that play an important role in the control of emotions and specific 
behaviors, such as the consumption of drugs of abuse. 5-HT elicits signal 
transmission between neurons by activating 5-HT receptors, subdivided into seven 
subtypes mediating both excitatory and inhibitory outcomes. All serotonin receptors 
are seven-transmembrane domain receptors coupled with G protein, except the 5-
HT3 subtype which is a ligand-gated ion channel (Berger et al., 2009). 
Ethanol particularly interferes with 5-HT3 ionotropic receptors. Alcohol exposure 
increases the electrical signal generated by 5-HT3 receptors in the brain, leading to a 
massive stimulation of neuronal synapses linked with serotonergic terminals (Pivac 
et al., 2004). As a consequence, the firing of adjacent non-serotonergic neurons 
increases the release several neurotransmitters strongly involved in ethanol addiction, 
such as dopamine (as discussed later in Section 1.3.7). Higher levels of serotonin 
metabolites are found in blood and urine after a drinking session, suggesting that 
alcohol augments the release of this neurotransmitter (Lovinger, 1999). Serotonergic 
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1.3.6 Ethanol and Opioids 
 
Opioid systems represented by the endogenous opioids, endorphins, encephalins and 
dynorphins appear to influence alcohol drinking behavior by interacting with the 
mesolimbic dopamine system (Section 1.3.7) (Janecka et al., 2004). Furthermore, 
increases in extracellular endorphin levels in the nucleus accumbens were found 
following acute alcohol intake, acting independently from the mesolimbic dopamine 
system and demonstrating a dual mechanism exerted by opioids (Olive et al., 2001). 
As a consequence, positive alcohol reinforcement could be partly due to the release 
of endogenous opioids in the brain with their G-protein coupled ?, δ, and κ subtypes 
of receptors (Janecka et al., 2004). 
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1.3.7 Ethanol and Dopamine: mesocorticolimbic dopaminergic 
pathways 
 
Dopamine (DA), a catecholaminergic neurotransmitter released by neurons as a 
signaling molecule, plays a pivotal role in several distinct pathways in the CNS, 
controlling hormonal release as well as being involved in the control of motor 
functions and mood tone (Schultz, 2007). DA is also implicated in psychoses and 
neurodegenerative diseases; for example, a drastic reduction of striatal dopamine 
content, due to the loss of dopaminergic neurons in the midbrain area (i.e. the 
substantia nigra), is a hallmark of Parkinson's disease (Bazzu et al., 2010; Serra et 
al., 2002; Serra et al., 2000) 
When released into the synaptic cleft, DA interacts with its receptors, classified into 
D1- and D2-like families. Both families are G-protein coupled receptors, but their 
activation exerts different neuronal effects. The D1-like receptor family includes D1 
and D5 subtypes, postsynaptic receptors whose stimulation leads to activation of the 
enzyme adenylate cyclase, increasing the intracellular concentration of the second 
messenger cAMP (cyclic adenosine monophosphate). In contrast, the D2-like family 
of receptors (D2, D3 and D4 subtypes) located on both pre- and postsynaptic 
membranes, inhibit the production of cAMP by directly acting on adenylate cyclase 
(Sesack, 2002). 
The DA transporter (DAT) is responsible for determining the duration of dopamine’s 
interaction with its receptors, removing this neurotransmitter from the synaptic cleft. 
Usually, the dopaminergic neurons are just tonically active and DAT uptake activity 
is quiescent (Nirenberg et al., 1997). When they are excited, however, the synapse 
floods with DA, leading to briefly increased tone (phasic activation) of 
mesocorticolimbic dopaminergic pathways. The increased dopaminergic activity 
which occurs in the nucleus accumbens increases both D1- and D2-type receptor 
signaling.  
DA has been demonstrated to play a key role in modulating fundamental survival 
mechanism of species, such as how to obtain food, water or mating. These action are 
defined as reward-motivated behaviors (Hyman et al., 2006), because they are 
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associated with the activation of a specific brain neuronal reward system, which uses 
DA as neurotransmitter: the mesocorticolimbic dopaminergic system. 
This pathway has been widely accepted to be the epicenter of reward in the brain, 
and has been proposed to be involved in movement, motivation, learning, arousal and 
orgasm, emotion and attention (Gonzales et al., 2004). Each kind of reward that has 
been characterized (for example, food, sex, drug of abuse, gambling, etc.) augments 
the level of released DA in the associated brain areas (see below), whereby both 
responses to natural rewards and various drugs of abuse show several similarities and 
shared pathways (Avena and Hoebel, 2003).  
The mesocorticolimbic dopaminergic pathway begins in a region of the midbrain 
called ventral tegmental area (VTA) and reaches the limbic system through 
connections with the nucleus accumbens, amygdala, hippocampus and medial 
prefrontal cortex (Figure 4). 
 
 
Figure 4: Scheme of the mesocorticolimbic dopaminergic system  
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The VTA consists of dopaminergic, GABAergic interneurons, and glutamatergic 
neurons located in the midbrain. The dopaminergic cell-body group (A10) is the 
origin of the mesocorticolimbic dopamine system. Even though quite small in 
absolute terms, it represents the main cluster of DA cells in the human brain. The 
bodies of these neurons project to prominent terminal areas such as the nucleus 
accumbens and the prefrontal cortex (Haber, 2002). 
 
Whilst drugs of abuse are markedly heterogeneous in chemical structure, as well as 
in molecular targets and the related physiological effects, it has been widely 
ascertained that they all share a common effect of enhancement on the mesolimbic 
DA pathway, leading to increased release of DA in the nucleus accumbens 
(Mogenson and Huang, 1973). Hence, the reinforcing properties of drugs such as 
cocaine, amphetamine, opiates or nicotine are related to their ability to increase, at 
least acutely, the levels of this neurotransmitter in specific areas and activate the 
multisynaptic dopaminergic reward circuitry (Wise and Rompre, 1989). 
 
Ethanol too has been found to have the same profile of interaction with the 
dopaminergic system as many drugs of abuse. As a matter of fact, acute ethanol 
assumption promotes an increase of activity in the mesolimbic DA system, causing 
higher levels of dopamine release, predominantly in the nucleus accumbens (Di 
Chiara and Imperato, 1986; Koob and Bloom, 1988). It has been observed that 
alcohol causes a dose-dependent enhancement in the spontaneous firing rate of 
dopaminergic neurons in vivo in the VTA; indeed, dopaminergic neurons located in 
the VTA are preferentially activated by lower doses of ethanol compared to adjacent 
DAergic neurons of the substantia nigra (Gessa et al., 1985). Furthermore, ethanol 
directly excites dopaminergic VTA reward neurons when synaptic transmission is 
blocked (Brodie et al., 1999). Although subjected to diverse studies, the molecular 
mechanisms through which ethanol alters the function of the mesolimbic DA system 
have still not been entirely elucidated (Karahanian et al., 2011; Mostofa et al., 2003; 
Munson et al., 1995). 
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1.4 Ethanol and Alcoholism 
 
The continual consumption of ethanol can cause alcoholism, a pathological chronic 
relapsing disorder characterized by the high and compulsive consumption of alcohol, 
and loss of control over intake.  
The long-term abuse of alcohol produces physiological changes in the brain. The 
neurotransmitter systems disrupted by acute ethanol are even more deeply altered 
during a chronic exposure, generating adaptive processes resulting in a compensatory 
balance. The changes in the activity of GABA, glutamate, serotonin, opioids and 
other neuronal systems concur to develop neuroadaptive phenomena, such as 
sensitization, tolerance and psychophysical dependence. 
Sensitization seems to be the first step leading a subject from alcohol use to abuse, 
due to an increment in the reinforcement value of ethanol after repeated exposure, 
when an individual associates the liking of alcohol with the positive stimulus of 
wanting (Robinson and Berridge, 1993). After repeated consumption of alcohol, the 
wanting is amplified into a pathological status characterized by craving for the drug. 
The mesocortical DA pathway is involved in this sensitization phenomenon (Gilpin 
and Koob, 2008).  
Tolerance is observed when a drinker shows a reduced physiological or behavioral 
response after consuming the same dose of alcohol. So, as a consequence of the 
decrease in the reinforcing efficacy of the drug, the individual requires progressively 
higher doses of ethanol to reproduce the effect experienced before (Leblanc et al., 
1975). Tolerance is mediated by changes in metabolism of neurotransmitters and the 
activity of their receptors. GABA-A receptor function is decreased by long-term 
alcohol consumption, as the result of a reduction in the number of receptors, or by 
changes in their protein structure, resulting in a decrease in GABAergic 
neurotransmission tone. On the other hand, the activity of NMDA receptors is up-
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This dysregulation also involves neural circuits implicated in the control of 
motivational processes (arousal, reward, stress, etc.), such as serotonin, opioids and 
norepinephrine. The impairment of those systems deeply contributes to the allostatic 
state that characterize the development of alcohol dependence (Hardman and 
Limbird, 2005; Volkow et al., 2007). Furthermore, it has been indicated that 
corticotrophin-releasing factor may be involved, and that the neuropeptide-Y brain 
antistress system may be compromised (Roy and Pandey, 2002). 
As described above, the CNS of an alcoholic becomes unbalanced in the delicate 
physiological equilibrium between excitatory and inhibitory transmission. In chronic 
ethanol exposure, the brain tries to compensate the disequilibrium by antagonizing 
the depressant effect of alcohol, both by decreasing the activity of inhibitory 
transmission, as well as by increasing the glutamatergic excitatory circuits 
(Valenzuela and Harris, 1997).  
But when alcohol consumption is reduced or suddenly interrupted, the disequilibrium 
manifests as a withdrawal syndrome, characterized by a state of hyperexcitation, 
anxiety and delirium tremens (Sullivan et al., 1989). Withdrawal states result from 
the lack of ethanol effects on the compensatory changes induced by tolerance. In 
attempting to restore the “pathological neurotransmitter equilibrium” and avoid the 
negative psychophysical effects, the individual needs a continuous consumption of 
ethanol (Valenzuela and Harris, 1997). Appearance of the withdrawal syndrome 
represents the irrefutable signal of physical dependence (O’Brien, 2005).  
The physical dependence is always accompanied by a psychological component 
characterized by the increase of the motivation to compulsively seek and ingest 
alcohol. Rewarding effects of alcohol have an extremely important role (Littleton 
and Little,1994). Alcohol removal produces a negative-affective state, that merges 
with physical withdrawal effects to increase the propensity for relapse in recovering 
alcohol-dependent subjects (Koob, 2003). Alterations in the stress system, as well as 
decreases in the dopaminergic reward pathway function, seem to be implicated in 
psychological withdrawal symptoms and in the susceptibility to alcohol-seeking 
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In the critical phase of transition from a controlled use of alcohol to dependence, 
positive reinforcement is essential, being linked with the activation of the 
mesocorticolimbic system and the increase in dopaminergic neuronal activity in the 
VTA (Theile et al., 2011; Karahanian et al., 2011). Reinforcement can be defined as 
a process in which a response or behavior is strengthened, based on previous 
experiences (Gilpin and Koob, 2008), and is characterized by positive or negative 
side effects.  
Alcohol-drinking behavior is determined and maintained by both positive and 
negative reinforcement, and their specific contribution varies during the transition 
from ethanol-controlled use to addiction.  
Positive reinforcement in alcoholism seems to be linked to rewarding stimulus, such 
as the euphoric effects, which increase the probability that the individual exhibits 
alcohol-seeking behavior in the future. Dopamine, serotonin and opioid peptide 
neurons, as well as GABAergic interneurons, acting on the VTA and nucleus 
accumbens, fire during acute ethanol assumption, such as in the early stages of 
dependence, as well as in the binge stage, and are deeply involved in the positive 
reinforcement (Rassnick et al., 1993; Gonzales et al., 2004). The positive 
reinforcement due to the opioidergic system is reduced by antagonists of opioid 
receptors (e.g., naltrexone) which, acting on the VTA, nucleus accumbens, and 
central nucleus of the amygdala, decrease the rewarding effects of ethanol, justifying 
their use in alcoholism pharmacological therapies (Williams and Broadbridge, 2009; 
Koob, 2003). Acamprosate is a GABA analogue capable of reducing the relapse in a 
dose-dependent way, having a similar action and efficacy as naltrexone (Paille et al., 
1995.) 
Negative reinforcement occurs in alcohol dependence whenever motivational and 
affective symptoms such as anxiety, dysphoria, irritability, and emotional pain 
appear. These effects manifest during withdrawal or in the absence of alcohol, 
subsequent to previous discontinuation of ethanol intake. As a consequence, 
individuals, who already experienced alcohol withdrawal, could be pushed to drink 
again to prevent or alleviate the anxiety, or more generally to avoid and escape from 
the aversive stimulus they previously experienced (Gilpin and Koob, 2008). 
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 Due to its features, the role of negative reinforcement increases following the 
transition to dependence, although it seems to appear even in earlier stages (Boileau 
et al., 2003). Key elements sustaining negative reinforcement and the stress circuit 
are corticotrophin-releasing factor and norepinephrine-releasing neurons. Their 
interaction with GABA interneurons in the central nucleus of the amygdala increases 
during the development of the allostatic state (Rassnick et al., 1993). 
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1.5 Techniques used in vivo to study ethanol in the brain 
 
By outlining above the significant neurobiological implications of ethanol ingestion 
and addiction, it clearly emerges how critical and essential it is to further deepen our 
knowledge of alcohol toxicokinetics in humans. The varied and complicated set of 
interactions with several neuronal pathways makes the investigation of ethanol 
pharmacodynamics quite difficult. Several researchers focused their efforts to better 
understand the causes and the mechanisms involved in this very complex disorder; 
however, it is arduous to reproduce all the features of alcoholism. Different reliable 
animal models, recreating the specific symptoms of alcohol dependence, have 
demonstrated their usefulness in investigating alcohol-related neuronal changes. 
Alcohol addiction is easily reproducible in mice and rats (e.g., self-administration), 
and shows similar characteristics of the different stages of dependence in humans, 
including binge-intoxication, relapse, withdrawal-negative effects, and 
preoccupation-anticipation stages (Loos et al., 2013). Even if much progress has 
been made, many other unsolved questions and issues remain for further 
investigation. 
 
Ethanol detection in the brain kindles a particular interest, especially the monitoring 
of its concentration dynamics. New technologies are being combined with traditional 
approaches to study the transition from alcohol use and abuse to dependence, using 
the most appropriate techniques. Techniques used to measure ethanol concentration 
in the brain range from invasive to non-invasive approaches.  
Non-invasive methods employ spectroscopic techniques such as magnetic resonance 
spectroscopy (MRS), magnetic resonance imaging (MRI) or positron emission 
tomography (PET) to monitor directly alcohol and its metabolites, both in animals 
and humans. 
Invasive techniques include microdialysis, the most widely used in the last decades, 
and biosensors, new emerging and promising tools.  
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Both techniques are very reliable, but due to the necessity to implant probes in the 
tissue they can only be used in animal models and, except with some exceptions, 
suitable for preclinical studies only (Rocchitta and Serra, 2013).  
 
In particular, we will focus on biosensors by generally describing the principles of 
their function. Because an accurate disquisition of the large and growing field of 
biosensors fall outside the remit of this dissertation, we will limit the discussion to 
just electrochemical biosensors, specifically amperometric biosensors that use 
enzymes as the biological element (Section 1.5.3). These have a number of 
advantageous features that make them particularly applicable in neurochemical 
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1.5.1 Spectroscopic techniques  
 
Clinical and preclinical studies of ethanol kinetics have been carried out by means of 
spectroscopic techniques, exploiting their main advantage, i.e., the absolute non- 
invasiveness of the procedures to monitor changes in ethanol tissues concentrations 
in animal models as well as in humans. 
Despite the fact that the ethanol monitoring range is of the order of millimolar, 
spectroscopic techniques show a limitation in its temporal range of detection, 
allowing monitoring sessions of only a few minutes. Additionally, even when no 
tethering is required, the experimental procedure requires that both animals as well as 




Magnetic resonance spectroscopy (MRS), also known as nuclear magnetic resonance 
(NMR) spectroscopy, is a noninvasive analytical technique used to study metabolic 
changes in numerous pathologies and in chemistry applications. MRS allows the 
identification and quantification of a number of molecules in samples of different 
origin (McRobbie et al., 2007). 
In-vivo MRS records peaks of different radio frequencies and intensities given by 
molecules that possess fundamental molecular properties, viz. nuclear spins, typical 
resonance frequencies, spin couplings, and unique relaxation properties. Usually, the 
most studied nuclei are proton [1H], carbon [13C], phosphorus [31P], lithium [7Li], 
fluorine [19F], and sodium [23Na]. Among these, hydrogen is the main nucleus 
investigated nucleus due to the high sensitivity to the hydrogen (1H) nucleus and its 
abundance in molecules. Clinical imaging of the brain is commonly coupled to 
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MRS has been widely used in vivo to assess brain alcohol levels, especially because 
it allows monitoring of ethanol-induced changes in the spectroscopically visible 
brain metabolites (Adalsteinsson et al., 2006; Ross and Bluml, 2001; Sammi et al., 
2000; Hetherington et al., 1999). Ethanol is detectable by MRS via the methyl 
protons that can be identified by a distinctive triplet at the 1.3 ppm (parts per million) 
region of the spectrum. 
As a matter of fact, because the two carbon atoms of the aliphatic chain are in 
different structural environments, each of them produces a distinct signal in the 13C 
NMR spectrum of ethanol. The carbon linked to the more electronegative oxygen 
shifts its signal toward the left of the spectrum, while the carbon of the methyl group 
appears at the right of the spectrum. 
Because 1H MRS signals are considerably affected by their intramolecular 
environment, ethanol metabolite signals do not interfere with the signal of ethanol 
itself in the brain, which yields the most intense signals in such spectra (Xiang and 
Shen, 2011; Rooney et al., 2000; Fein and Meyerhoff, 2000; Hanstock et al., 1990). 
 
1.5.1.2 Isotopic techniques  
 
Isotopic techniques are widely used to detect a wide variety of chemicals, such as the 
metabolites of energy substrates in the brain. Combined with a radioactivity test and 
PET, 14C- and 11C-labeled ethanol molecules were used in a study with the aim to 
monitor ethanol metabolites in humans (Mushahwar and Koeppe,1972). However, 
the use of these isotopes had some disadvantages, in which a large dose of 14C-
labeled chemicals are known to produce dangerous radiation effects, while 11C-
labeled ethanol shows a short half-life of about 20 minutes (Rocchitta and Serra, 
2013). 
However, in-vivo 13C MRS, combined with the infusion of 13C-labeled ethanol, is 
commonly used to directly detect both ethanol and its metabolites in the CNS; 13C-
acetate, produced by aldehyde dehydrogenase, is extremely useful to study cerebral 
metabolism, neurotransmission, and neuronal–glial interactions in both humans and 
animals (Yun Xiang and Jun Shen, 2011; Dimitrakopoulou-Strauss et al., 1999). 
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1.5.2 Microdialysis  
 
Microdialysis has been one of the most common techniques used in neuroscience 
since the 1970s to obtain information about the interstitial fluid composition, by 
inserting a dialysis probe into brain tissues (Ungerstedt and Hallström, 1987; 
Tossman and Ungerstedt, 1986; Delgado et al., 1972). The principles of 
microdialysis are the same as classical dialysis: the probe has a semipermeable 
membrane which separates two fluid compartments and allows passage and 
exchange of only low molecular weight compounds (Nurmi et al, 1994). An 
appropriate fluid (Ringer) is perfused through the probe and neurochemical 
molecules diffuse in both directions depending on their concentration gradients to 
move in and out of the probe (Figure 5).  
 
 
Figure 5: Scheme of ethanol sampling by means of a microdialysis probe 
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In this way, microdialysis allows the simultaneous sampling and unambiguous 
assignment of a wide range of chemical species in the tissue extracellular space 
(Bazzu et al., 2012; Bazzu et al., 2011).  
However, this useful approach possesses some limitations such as invasiveness, poor 
temporal resolution, and the sensitivity of the chosen analytical technique, which is 
always needed to analyze the dialysate. The temporal resolution represents the main 
limiting factor, because several minutes are usually required to collect an adequate 
volume to allow the analysis of the sample by means of a suitable analytical 
technique, for example HPLC (High Performance Liquid Chromatography). 
Moreover, microdialysis is generally performed under non-equilibrium conditions. 
Thus, analyte concentrations are generally underestimated, because dialysate 
concentrations represent only a small fraction (which depends on the flow rate) of the 
real concentrations of the medium surrounding the microdialysis probe (Brunner and 
Langer, 2006). Despite these technical limitations, microdialysis has been 
demonstrated to be appropriate to detect ethanol levels in the CNS.  
After sampling, ethanol concentration in the interstitial fluid is usually measured by 
means of gas chromatography technique (generally supplied with a headspace 
autosampler and flame ionization detector) or via an enzymatic assay, down to very 
low micromolar concentrations (Peris et al., 2006; Quertemont et al., 2003). 
In vivo microdialysis has been applied in preclinical studies to investigate the 
relationship between ethanol-related behaviors and neurochemical variations 
(Gonzales et al., 1998). Furthermore, local perfusion of ethanol in specific brain 
region has been used to investigate the potential involvement of local mechanisms, 
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1.5.3 A new possible approach: Biosensors 
 
The major limitations emerging from the description of the techniques described 
above are related to many factors. For spectroscopic techniques, despite their non-
invasive approach that make them reliable for in vivo experiments in humans, ethanol 
cannot be detected for concentrations lower than millimolar levels, and only for a 
short time. Moreover, labeled chemicals could be toxic for long-term exposure, and 
the technique is applicable for only non-dynamic experiments.  
For microdialysis, invasiveness limits its use in clinical trials, as do the need to use 
connecting tubes to carry out the experiments, and the low temporal resolution, 
especially to achieve an excellent recovery fraction by varying some microfluidic 
parameters (Bazzu et al., 2012; Bazzu et al., 2011). 
 
Because ethanol concentration in the brain can vary dynamically, as well as those of 
the neurotransmitters it affects, its study would require a real-time approach. 
Biosensors are emerging tools which have already been demonstrated to be useful 
and reliable in the dynamic detection of a number of neurobiological molecules on a 
very short time-scale (Rocchitta et al., 2013; Secchi et al., 2013; Rocchitta et al., 
2012; Mohd Zain et al., 2012; Calia et al., 2009; McMahon and O'Neill, 2006; 
Lowry et al., 1988). As a consequence, the monitoring of fast ethanol concentration 
changes represents an ideal field of application. 
 
The biosensing technique is relatively recent, having been developed in the last 
decades thanks to its advantageous versatility, variety of applications, and in 
particular for its high temporal and spatial resolutions. Biosensors allow the detection 
of very low concentrations of several analytes in vivo. Because of their invasiveness, 
these tools have not proven to be suitable for clinical studies in humans, but they are 
still extremely reliable for preclinical studies of neurochemical modifications in the 
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According to the IUPAC definition, a biosensor is a self-contained integrated device 
which is capable of providing specific quantitative or semi-quantitative analytical 
information using a biological recognition element (biochemical receptor) which is 
in direct spatial contact with a transducer element. A biosensor should be clearly 
distinguished from a bioanalytical system, which requires additional processing 
steps, such as reagent addition. Furthermore, a biosensor should be distinguished 
from a bioprobe which is either disposable after one measurement, i.e. single use, or 
unable to continuously monitor the analyte concentration (Thévenot et al., 2001). 
 
A biosensor basically consists of two elements:  
 
• the sensitive biological element, such as enzymes, antibodies, nucleic acids, cells 
or tissues which selectively recognize and reacts with the analyte (e.g., enzyme 
substrate, antigen, complementary DNA, etc.) and generates a chemical or 
physicochemical signal. Enzymes are the most common type of biological 
element used in biosensors.  
 
• a transducer which converts the signal resulting from the biological reaction into 
an electronic one. The intensity of the electronic signal generated on the 
transducer surface is directly or inversely proportional to the analyte 
concentration. An amperometric electrode is the most common transducer used in 
biosensors, and enzyme-based amperometric biosensors were designed and used 
in this thesis. 
 
Owing to electrical interference generated by the electronic components and the 
transducer itself, the signal deriving from the transducer is usually low and overlaid 
on a noisy baseline. The subtraction of a reference baseline signal, the amplification 
of the resultant signal difference and the use of electronic filters allows minimization 
of the unwanted signal noise, thus generating an analyte-derived current. The 
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Finally a microprocessor converts the current into concentration units, easily 
monitorable on a computer display. 
 
So, biosensors basically differ from chemical sensors by the presence of an 
immobilized biological element that permits the quantification of analytes by means 
of the biological reactions. Biosensors are normally grouped in three generations, 
based on the mechanism of how the response is generated: 
• In first generation tools, the product or by-product of the biological reaction 
diffuses to the transducer surface, giving the electrical response. 
• Second generation biosensors use specific mediators as intermediate between the 
biological reaction and the transducer, with the aim to improve the response.  
• Finally, the third generation includes biosensors in which the response is caused 
by the biological reaction itself. In this case, no product or mediator is directly 
involved. 
 
Biosensors can use very different transducers. For example, electrochemical (i.e., 
amperometric, potentiometric or conductometric) and fiber optical transducers are 
commonly used in biosensors (Gronow, 1999). Each kind can be functionalized with 
a different biological elements. For the aim of this dissertation only a brief 
description of operation principles of the main electrochemical transducers is given.  
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1.5.3.1 How amperometric electrochemical transducers work 
 
Electrochemical biosensors allow the specific analysis of several species with high 
selectivity and sensitivity in very rapid time. These tools are utilized in many fields 
for biochemical, forensic, industrial and environmental analysis. Potentiometric, 
conductometric and amperometric sensors are the main kind of electrochemical 
transducers (Gronow, 1999; Thévenot et al., 2001). 
 
Potentiometric detection is based on the measurement of the potential generated by 
charge accumulation. Potentiometric biosensors exploit a reaction between a 
sensitive organic membrane or surface towards the analyte to generate a potential 
proportional to the logarithm of the concentration of the electrochemically molecule, 
compared to the reference electrode potential. 
 
Conductometric biosensors exploit conductivity change of a medium as detection 
method. They are commonly used to quantify the change of the electrical 
conductivity of cell solution, in which the majority of reactions lead to a 
modification of solution ionic composition.  
 
However, a very large number of biosensors have been developed based on 
amperometric transducers. In the majority of designs, immobilized enzymes 
represent the biological element, since they guarantee reproducible results as the 
same catalytic activity is preserved for a series of analyses. Amperometric 
transducers are therefore to be considered as reliable components when developing a 
biosensor based on an enzyme. 
Amperometric biosensors function by the production of a current when a potential is 
applied between two electrodes. The measurable current is generated by a biological 
reaction, usually enzyme catalyzed. Amperometric biosensors indirectly detect non-
electroactive analytes by means of the biological reactions generating an 
electroactive product or by-product, while a constant potential is being applied.  
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This approach is required because many biological compounds are non-electroactive. 
Then, the electroactive compound reacts with the transducer and leads to a change of 
current intensity proportional to the initial concentration of analyte (Kowalska et al, 
2011; Vasylieva et al, 2011; Njagi et al, 2010; Ahmet Koyun, et al., 2012). 
Amperometric devices are able to quantify the electric signal produced both with 
voltammetric or amperometric techniques: 
 
- Amperometry: a constant potential is applied between electrodes to drive the 
current  
 
- Voltammetry: measures the current under controlled potential variations 
 
CPA (Constant Potential Amperometry) is an amperometric technique which allows 
the measurement of the signal by using a hardware unit (potentiostat) to apply a 
constant potential. Commonly, in vitro amperometric experiments are performed in 
an electrochemical cell, using a three-electrodes system:  
 
1-Working electrode (WE) 
2-Reference electrode (RE) 
3-Auxiliary (counter) electrode (AUX) 
 
The measured current (faradaic current) is generated by the reduction (cathodic) or 
oxidation (anodic) of the target molecule at the working electrode surface. 
Biosensors are forms of working electrodes. Their potential is maintained constant 
relative to a reference electrode by the potentiostat, which is able to adjust the 
‘balancing’ current generated at the auxiliary electrode. In this way, biosensors work 
under constant voltage conditions, and the measured current resulting is related to the 
analyte concentration. 
The reference electrode establishes the electrical potential against which the applied 
potentials is measured. One of the most common reference electrodes is the Ag/AgCl 
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The saturated calomel electrode (SCE: Hg/Hg2Cl2/KCl(sat.)) is also widely used.  
The auxiliary or counter electrode consists of electrochemically inert materials (such 
as gold, platinum, stainless steel, or carbon), and generally has a bigger surface area 
than of the working electrodes. The counter electrode has a double operational mode: 
if the working electrode is operating as an anode, the counter electrode works as a 
cathode and vice versa. The half-reaction which occurs at the auxiliary electrode 
surface has to be fast enough not to limit the reaction at the working electrode. The 
potential of the auxiliary electrode is always adjusted (by the potentiostat) to balance 
the reaction occurring at the working electrode, allowing the potential of the working 
electrode to be measured versus the reference electrode (Kissinger and Heineman, 
1996; Bard and Faulkner, 2000; Zoski, 2007). 
Finally, among voltammetric techniques, cyclic voltammetry (CV) is generally used 
to determine diffusion coefficients and half-cell reduction potentials (Ahmet Koyun, 
et al., 2012). 
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1.5.3.2  Enzymes suitable for developing an ethanol biosensors: AOx 
vs ADH 
 
Although other biological systems may be utilized in biosensor design (antibodies, 
nucleid acids, whole cells, tissues, etc.) we will focus on enzymes, the more 
commonly-used biologically responsive material, and particularly on suitable 
enzymes to develop an ethanol biosensor: oxidoreductase Alcohol Oxidase (AOx) 
and Alcohol dehydrogenase (ADH). 
Enzymology refers to an oxidoreductase as an enzyme catalyzing the transfer of 
electrons from one molecule (electron donor) to another one (electron acceptor). The 
enzymatic reaction requires the presence of O2, involves a reductant specie, an 
oxidant one, and a specific cofactors such as NAD+, NADP (nicotinamide adenine 
dinucleotide phosphate), FAD (flavin adenine dinucleotide) or FMN (flavin 
mononucleotide). The big family of oxidoreductases enzymes includes the subclasses 
of dehydrogenase and oxidases enzymes. 
Alcohol dehydrogenase belongs to the big subclass EC 1.1.1 of dehydrogenases, 
oxidizing enzymes which convert the substrate by a reduction reaction that transfers 
one or more H− to a cofactor, which represents the electron acceptor. The subclass 
includes enzymes with NAD or NADP as acceptor such as malate dehydrogenase, 
glucose 1-dehydrogenase, L-lactate dehydrogenase and many others have been used 
in biosensing (http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/intro.html). 
Aldehyde dehydrogenase catalyzes the reaction (eq 1, see also Figure 2, Panel A): 
Ethanol + NAD+ → Acetaldehyde + NADH + H+   (1)
 
The subclass of oxidases, EC 1.1.3, consists of enzymes that catalyze an oxidation-
reduction reaction involving molecular oxygen as the electron acceptor, being 
reduced to hydrogen peroxide (H2O2) or water. Even oxidase enzymes are usually 
linked to a cofactor. Malate oxidase, glucose oxidase, choline oxidase, cholesterol 
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The flavoprotein alcohol oxidases (Alcohol: O₂ Oxidoreductase) are enzymes that 
catalyze the oxidation of alcohols to the corresponding carbonyl compounds by 
forming hydrogen peroxide. Based on substrate specificity, they are divided in four 
groups: 
 
- SCAO   short-chain alcohol oxidase 
- LCAO   long-chain alcohol oxidase 
- AAO   aromatic alcohol oxidase 
- SAO   secondary alcohol oxidase  
 
In particular, Alcohol Oxidases EC 1.1.3.13 are SCAO flavoenzymes employing 
FAD as cofactor. These oligomeric enzymes consist of eight identical sub-units, each 
strongly bound to a FAD molecule (Azevedo et al., 2005). 
AOx are chiefly present in bacteria, yeast, fungi, plant, insect, and mollusks. In 
particular, alcohol oxidases extracted from the yeast Hansenula polymorpha are 
contained in peroxisomes, where are involved in the first reaction of methanol 
utilization pathway. Because AOx has a low affinity for oxygen, a great number of 
this enzymes are synthesized to supply the poor catalytic activity and satisfy the 
cell’s metabolic need (Cregg et al., 1989). These aspecific oxidoreductases are able 
to oxidize short-chain, saturated primary alcohols (i.e. methanol, ethanol, propanol or 
butanol) specifically acting on the CH-OH group of the electron donor. Unsaturated 
or branched-chain alcohols, as well as secondary alcohols, are not substrates of 
Alcohol Oxidase. AOx catalyzes the biochemical reaction (eq 2): 
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Structural and kinetics characteristics of Alcohol Dehydrogenase have been already 
discussed in the ethanol pharmacokinetics Section 1.2 above. ADH is involved in the 
major pathway of ethanol metabolism, and its efficiency is closely related with the 
amount of NAD+ co-factor available in the cytoplasmatic environment.  
Several ADH-based ethanol biosensors have been developed and used in agri-food, 
chemical, forensic, clinical and industrial fields, generally demonstrating a very good 
stability and specificity (Gao et al., 2013; Zhen et al., 2011; Alpat and Telefoncu, 
2010; Luo et al., 2008; Luo et al., 2008b; Liaw et al., 2006; Walters et al., 1998). 
Nevertheless, ADH-based biosensors require the external addition of NAD+ as co-
factor which needs to stay in intimate contact with the enzyme. In contrast, AOx-
based tools do not require the adding of supplement cofactor in the medium to 
perform its catalytic reaction, because the FAD cofactor is already tightly bound to 
the redox center. 
This important issue could result in limiting some uses of ADH-based biosensors, 
and drives the choice of using the more practical AOx as the biologically responsive 
material. 
Moreover, in AOx-based biosensors it is simple to follow the changes of ethanol 
concentration by monitoring the decreasing of oxygen tension or alternatively by 
monitoring the concentration of the by-product hydrogen peroxide, which is easily 
oxidizable or reducible at the transducer surface. Because of these advantages, 
flavin-based redox enzymes are now widely used in several industrial processes 
(Smyth et al., 1999; Patel et al., 2001; Hämmerle et al., 2011), and make them 
extremely reliable for the development of miniaturized biosensors (Secchi et al., 
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The detection of ethanol concentration dynamics in the brain kindles a particular 
interest because alcohol is the most widely-used psychoactive drug with global 
socio-economic and health consequences. Unregulated consumption can lead to toxic 
actions on peripheral organs and the CNS, as well as the development of a severe 
progressive disease called alcoholism, characterized by the disruption and alteration 
of the main CNS neurotransmitter systems. 
 
Despite a wide range of studies, using different approaches, in attempts to investigate 
the complicated range of ethanol mechanisms of action and interactions in the brain, 
an insufficiency of detailed knowledge remains. This paucity is also related to 
limiting factors, such as time resolution, that affect the reliability of the detection 
methods used to date, mainly microdialysis and spectroscopic techniques. 
 
Because ethanol concentration in the brain can vary dynamically, as do those of the 
neurotransmitters it affects, its optimal study would require a real-time approach, in 
which the temporal gap between ethanol arrival in the CNS and its interaction would 
be as short as possible. In this regard, the emerging ‘biosensing’ technique has been 
demonstrated to be a successful approach that allows the quantification of specific 
neurobiological molecules with high selectivity and sensitivity on a near real-time 
time scale. 
 
Thus, the aim of this study was to develop, characterize and optimize an implantable 
amperometric biosensor, capable of real-time monitoring of the fast ethanol 
concentration changes in brain ECF of animals, to better clarify the cause-and-effect 
relationships existing between alcohol and the neurotransmitter systems it affects, as 
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3.1 Chemicals, reagents and solutions 
 
All chemicals were purchased from Sigma–Aldrich (Milano, Italy). Phosphate 
buffered saline (pH 7.4) was obtained by dissolving NaCl (8.9 g), NaOH (1.76 g), 
and NaH2PO4 (6.89 g) powders in 1 L of bidistilled water. 
Alcohol oxidase stock solutions range from 100 to 800 U/mL were prepared in PBS 
from Hansenula polymorpha (AOx, EC 1.1.3.13). Hydrogen peroxide (H2O2) stock 
solution (100 mM) was prepared in bidistilled water by proper dilution of the original 
30 % (w/w) solution. Ethanol solutions (1 M and 10 mM) were obtained from 
absolute ethanol by dilution in bidistilled water. Ascorbic acid solution (AA, 100 
mM) was prepared by dissolving L-ascorbic acid in 0.01 M HCl. Polyethyleneimine 
(PEI) and glycerol (Glyc) solutions were obtained by diluting the stock solutions 
(50% w/v and 87% w/v, respectively) in bidistilled water.  
ortho-Phenylenediamine monomer solutions (50, 100 and 300 mM oPD) were 
obtained by dissolution of the powder in different media. We tested several 
background electrolyte solutions, dissolving oPD in water (MilliQ, distilled or 
bidistilled), deoxygenated PBS, HCl (10 and 100 mM in water). Special caution is 
needed when using phenylenediamines. 
Glutaraldehyde (GA, 1% w/v) and bovine serum albumin (BSA, 10% w/v) solutions 
were prepared in bidistilled water, while polyurethane solution (PU, 1% w/v) was 
obtained by dissolving PU beads in tetrahydrofuran (THF).  
Teflon®-coated platinum (90% Pt, 10% Ir; Ø = 175 ?m) and silver wires (Ø = 250 
?m) were purchased from Advent Research Materials (Eynsham, England). Epoxy 
resin, Araldite-M and graphite were also purchased from Sigma–Aldrich (Milano, 
Italy). Ultrapure (>99.9%) oxygen and nitrogen were purchased from Sapio s.r.l. 
Special Gases Division (Caponago, Italy).  
Ranitidine hydrochloride solution was prepared in saline (0.9 % w/v) immediately 
before in vivo administration. 
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3.2 Biosensor fabrication and characterization 
 
All alcohol biosensor designs developed in this work were based on the same 
cylindrical geometry (see Figure 7, Section 3.4). Using a new sharp scalpel blade, the 
bare metal surface was exposed to a length of 1 mm (± 5%) and 125 ?m diameter by 
cutting away the Teflon insulation (50 ?m) from the tip of the wire (175 ?m 
diameter). For a more accurate result, the cut was made under an optical 
microscope.Polymer deposition strategies 
 
In this study we used different strategies in order to differentiate biosensors designs, 
modifying components and manufacture procedures. Nevertheless, all designs had in 
common the same approach for blocking interference species present in the target 
system, chiefly ascorbic acid (AA). Interference is a particularly marked problem 
when the biosensors are implanted in biological tissues for real-time monitoring. 
The electro-deposition of a poly-ortho-phenylenediamine (PPD) nanometer-thick 
membrane has proven to be a reliable procedure to drastically limit the passage of 
AA trough the biosensor component layers, allowing simultaneously a good 
hydrogen peroxide permselectivity (Kirwan et al., 2007). 
The PPD electrosynthesis was commonly performed starting from stock solutions of 
300 mM oPD monomer dissolved in pH 7.4 nitrogen-saturated PBS. All the solutions 
were freshly prepared immediately before electropolymerization, carried out 
amperometrically at +0.7 V versus Ag/AgCl reference electrode, for a standard time 
of 30 minutes. In order to maximize the selectivity of the device, PPD deposition 
occurred at different stages of manufacture for the various biosensor designs. At first, 
the PPD layer was deposited over the enzyme layer already loaded onto the platinum 
wire surface(Figure 8, Section 3.6). Another approach was to electro-deposit the PPD 
directly on the bare metal, before the enzyme loading (Figures 9-11, Section 3.6). 
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3.3 Further characterization of PPD deposition strategies 
 
In a different experimental environment, carried out in the Biosensors & 
Electrochemistry Laboratory of the School of Chemistry & Chemical Biology at 
University College Dublin, a further investigation of polymer deposition strategies 
was conducted. 
The main purpose was to examine the behavior and the efficiency of the PPD 
polymer when dissolving the ortho-phenylenediamine monomer in media other than 
PBS, which had been used up to this point in our laboratory in Sassari. Furthermore, 
different oPD concentrations (50, 100 and 300 mM) were investigated in this study. 
For each solution, pH and conductivity parameters were checked immediately after 
the electropolymerization was terminated (Figure 6). Electropolymerization 
conditions are shown in Table 7, Section 4.8 
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The effectiveness of novel polymer layers was assessed by comparing 
electropolymerization and AA-calibration parameter values such as Q(poly), 
t½(poly), Imax(AA), tmax(AA), as well as by calculating the biosensor apparent 
permeability parameters: P(HP)%, P(AA)%, and S% (see eqs 3–5, and Tables 8-9, 
Section 4.8). 
Q(poly) is the integral of the electrodeposition current, measured from the baseline 
recorded before the sensors’ immersion into the oPD solution and the limiting 
current reached at the end of the polymerization. Q(poly), expressed in mC. This is a 
measure of the number of electrons passed during the electropolymerization process, 
but not necessarily deposited on the surface, during the formation of the non-
conductive polymer.  
The time required by the sensors to complete the self-sealing electrodeposition 
(exponential decay; see Killoran and O'Neill, 2008) was evaluated and expressed in 
seconds as t½(poly) for each different monomer solution. It represents the half-life 
required to reach the polymerization limiting current, which indicates that no more 
electrons are transferred and the reaction is completed. 
Imax(AA) reflects the polymer properties to reject the AA during AA calibrations, and 
indicates the maximum current reached by the biosensors when 0.5 mM AA was 
injected in the electrochemical cell, calculated as the difference between the baseline 
current and the AA peak, expressed in nA. 
The value of tmax(AA) expressed in minutes indicates how fast the peak of 0.5 mM 
AA current (Imax(AA)) was reached, and is a measure of time response of the PPD to 
this interference compound (slow responses desirable). 
The sensitivity of the bare platinum electrodes to H2O2 and AA, as well as for after 
the PPD coating, was calculated by using the slopes of the linear calibration plots. 
Apparent analyte permeabilities parameters P(HP)% and P(AA)% (Rothwell et al., 
2009; O’Neill et al., 2008) have been used to quantify and compare the capacity of 
the various non-conducting polymers to allow H2O2 through while inhibiting the flux 
of the interference electroactive molecule AA to the electrode surface (Lowry and 
O’Neill, 1994; Centonze et al., 1994). 
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 These parameters were determined for individual electrodes and then averaged over 
populations of sensors for each design. In this way, the small differences in sensors’ 
dimension due to the Teflon removal (described in Section 3.4, see Figure 7), as well 
as intrinsic properties of PPD are normalized (Rothwell et al., 2009; O’Neill et al., 
2008). 
The H2O2 slopes (nA mM-1) were obtained from linear regression analysis of the 
respective calibration plots for H2O2 at the same Pt electrodes, before and after 
polymer deposition (eq 3). Three injections of H2O2 (40, 80 and 120 ?M) were made.  
 
   (3) 
 
 
Two injections of 0.5 and 1 mM AA were performed into the electrochemical cell. 
These concentrations were chosen because baseline brain AA levels are about 0.5 
mM (Miele and Fillenz, 1996) and could reach millimolar levels during a period of 
behavioral stimulation (Boutelle et al., 1989; O'Neill and Fillenz, 1985). The 
apparent AA permeability for Pt/PPD was defined for 1 mM AA, calculated by 
plotting the AA slopes (nA mM–1) obtained from linear regression analysis of the 
calibration plots for AA at the bare metal surface, versus the limiting currents 
obtained at 1 mM AA for PPD-modified electrodes (eq 4) 
 
  (4) 
 
 
where IAA(1 mM) at the bare electrode was determined as the numerical value of the 
slope (nA mM-1) of the linear calibration plots for AA, and IAA(1 mM) at Pt/PPD 
was the effective plateau response (nA) for 1 mM AA at the same Pt surface 
following its modification by the PPD polymer. Thus, both numerator and 
denominator in eq 4 correspond to AA responses at the same concentration, 
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Polymer selectivity (S%) was defined by eq 5 (O’Neill et al., 2008; Kirwan et al., 
2007) and represents the percentage interference by AA in H2O2 detection (Rothwell 
et al., 2009).  
For biosensor applications, the ideal value of S% defined in this way is zero. The use 
of equimolar concentrations in this definition allows S% to be interpreted as a 
permselectivity for two analytes with the same z-value, which indicates the number 
of electrons transferred per molecule. In the case of AA and H2O2 the z-value is 2. 
 
 
  (5) 
 
 
where IAA(1 mM) at Pt/PPD was the same as for eq 4, while IHP(1 mM) was 
determined as the numerical value of the slope (nA mM-1) of the linear calibration 
plots for H2O2 at Pt/PPD. Values of parameters are presented as mean ± standard 
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3.4 Alcohol Oxidase immobilization and kinetics 
 
The enzyme Alcohol Oxidase extracted from the yeast Hansenula polymorpha (EC 
1.1.3.13), was immobilized as the biological element in all biosensor designs, using 
different concentrations of solution enzyme (Figure 7). 
 
 
Figure 7 Schematic representation of ethanol biosensor  
 
Five different enzyme solutions were prepared by dissolving the enzyme powder in 1 
mL of PBS buffer (phosphate buffered saline), and the concentration expressed as 
units of protein dissolved per mL, specifically 100, 200, 400, 600 and 800 U/mL. 
One unit of AOx catalyzes the oxidation of 1 micromole of alcohol to aldehyde and 
hydrogen peroxide per minute in an air-saturated solution at pH 7.5 and 25 ºC. 
 
The technique of dip-evaporation, described here, was used to immobilize the 
enzymes at the biosensor surface. The biosensors were quick-dipped into the 
enzymatic solution, and then let dry at room temperature for 5–7 minutes in order to 
allow the evaporation of the solvent (water). This procedure was repeated 5, 10 or 15 
times, depending on the number of dips required to make each biosensor design. 
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As already discussed (Section 1.5.3.2), AOx is an eight-subunit flavoprotein, each 
containing a flavin adenine dinucleotide (FAD) cofactor molecule, fundamental for 
the enzymatic activity. This aspecific enzyme catalyzes the oxidation of primary 
short-chain aliphatic alcohols (such as ethanol or methanol) into their respective 
aldehydes.  
 
When AOx is immobilized in the biosensor, it reacts with its substrate to produce 
hydrogen peroxide (H2O2). With the use of the CPA technique (see Section 1.5.3.1), 
the hydrogen peroxide is amperometrically detected by oxidation at the Pt transducer 
surface, by applying a constant anodic potential of +0.7 V vs Ag/AgCl (eqs 6–8). 
The generated current is directly proportional to ethanol concentration (first 
generation biosensor, see Section 1.5.3.1) over the effective linear region of the 
Michaelis–Menten response plot. 
 
RCH2OH + AOx/FAD →RCHO + AOx/FADH2   (6) 
AOx/FADH2 + O2 → AOx/FAD + H2O2    (7) 
H2O2 → O2 + 2H+ + 2e−      (8) 
 
Immobilization procedures can affect the stability of the enzyme, and so the kinetic 
behavior of an enzyme deposited in a biosensor could change appreciably with 
respect to its activity in free solution.  
 
Conformational alterations of the protein, due to internal structural changes or 
limited access to the active site, as well as the characteristic of the supporting 
material, and the co-deposition of other biosensor components could represent the 
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As a consequence, Michaelis–Menten parameters for an immobilized enzyme are 
normally expressed in terms of apparent kinetics parameters, by expressing Vmax as 
Imax, indicating a current response. 
The form of the Michaelis–Menten enzyme kinetics equation (O’Neill et al, 2008), 
even for a two-substrate system (reactions 6 and 7), can be expressed for the alcohol 
EtOH as eq 9: 
 
?= ???max??1+ ???????M??(EtOH)?? 
      (9) 
Eq 9 expresses the rate of product conversion, and therefore of hydrogen peroxide 
flux, a fraction of which is detected at the electrode surface. Thus eq 9 is usually 
expressed in terms of current, for enzymes immobilized on amperometric biosensors, 
and IMAX is the maximum biosensor signal recorded when the enzyme is saturated 
with substrate (O’Neill et al, 2008). Therefore, different values of IMAX determined 
under the same conditions can reflect differences in enzyme activity (loading) on the 
biosensor surface. 
The apparent Michaelis constant KM is equal to concentration of substrate 
corresponding to half of the IMAX response and is mainly determined by how avidly 
the enzyme binds its substrate. The KM value is also important for determining the 
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3.5 Enzyme stabilizers: PEI and glycerol 
 
The use of enzyme stabilizers could be useful when immobilizing enzymes at a 
biosensor surface (Chaplin and Bucke, 1990). Generally enzyme stabilizers are 
positively charged molecules that interact with the negative charges of the proteins 
and help attain or recover the native conformation of the enzyme, limiting the 
internal structural changes and improving access to the active site. In this study we 
used two compounds, i.e., polyethyleneimine (PEI) and glycerol (Glyc) with the aim 
to improve the enzymatic activity of AOx when immobilized on the biosensor 
surface.  
PEI is a polycationic polymer formed by repeating units composed of an amine 
group (primary, secondary and tertiary) and a 2-carbon aliphatic spacer: –CH2CH2–. 
A 1% PEI solution was prepared by appropriate dilution of a 50% w/v commercial 
stock solution with bidistilled water. 
Glycerol is a viscous polyol compound with an hygroscopic nature widely used in 
pharmaceutical formulations, and soluble in water due to the presence of three 
hydroxyl groups. A 1% solution was prepared by diluting in bidistilled water the 
87% w/v stock solution. In addition, a mixed PEI-Glyc aqueous solution (both at 1%) 
was accurately prepared. 
Enzyme stabilizers were immobilized with the dip-evaporation technique (Section 
3.4), by alternating a dip in the stabilizer solution, letting the solvent (water) dry, and 
then dipping in the AOx solution. This protocol was repeated in relation to the 
number of dips needed. 
70 
 
Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
3.6 Biosensors designs 
 
The different strategies used to differentiate biosensor designs involved the variation 
of the sequence of PPD electro-deposition and of enzyme immobilization, as well as 
changes in the amount of enzyme loaded, the addition or co-addition of enzyme 
stabilizers, as well as their arrangement in the multi-layered pattern.  
During the first stages of ethanol biosensors development, a constant enzymatic 
solution concentration of 200 U/mL was chosen, while varying the other 
components. Once the best configuration was found, AOx concentration was then 
varied, as discussed before. The main features of the developed designs can be 
schemed in four general groups (Secchi et al., 2013; Rocchitta et al., 2012; see 
Figures 8–11). 
The first group is represented by the design in which AOx was deposited onto the 
platinum surface by dip-evaporation(Figure 8). Afterwards, the PPD layer was 
deposited upon the enzyme layer by electropolymerization (see Section 3.2). 
 
Figure 8: Schematic representation of the first design group 
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In the second group PPD layer was directly deposited on bare metal; the enzyme was 
then loaded over the polymer by dip-evaporation. After that, in order to immobilize 
the previously added layers, the biosensor was quickly dipped in a 1% PU solution 
(Figure 9). This precaution was also necessary because protease enzymes present in 
the brain can attack, damage and inactivate the core of the biosensor, i.e., the AOx. 
 
 
Figure 9: Schematic representation of the second design group 
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The third protocol involved PPD electrosynthesis on bare platinum, followed by the 
addition of AOx loaded by dip-evaporation. At this stage, however, an additional 
element was loaded: PEI, glycerol or their mixed solution were added by dip-
evaporation (indicated as Enzyme Stabilizers (E.S.) in Figure 10). Finally, the 





Figure 10: Schematic representation of the third design group 
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The fourth group followed the same scheme as the third one, but with a different 
“trapping net” used instead of the final PU layer. In fact, at this stage the biosensors 
were dipped in a BSA (10%) and GA (1%) solution. The cross-linking occurred 





Figure 11: Schematic representation of the fourth design group 
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3.7 In vitro biosensor calibration  
 
After their manufacture, all the biosensors were characterized in vitro. These studies 
were performed in an electrochemical cell containing 20 mL of fresh PBS at room 
temperature (23 ± 2 oC). The apparatus consisted of working electrodes (WE, ethanol 
biosensor, n=4), an Ag/AgCl (NaCl, 3 M) electrode as reference electrode (RE) and a 
large surface-area Pt wire as auxiliary electrode (AE). 
Ethanol and AA calibrations were performed with CPA (see Section 1.5.3.1) by 
applying a constant potential of +0.7 V versus Ag/AgCl, using the four-channel 
equipment (eDAQ QuadStat, e-Corder 410, eDAQ, Australia) to respectively test 
ethanol response and AA interference blocking, respectively. AA was chosen as the 
representative interference specie of biosensor function because of its relatively high 
levels in brain extracellular fluids, compared with other electroactive molecules 
(Ryan et al., 1997). In vitro response to ethanol was assessed by following a protocol 
of 16 successive injections (0–120 mM) of known volumes of ethanol stock solutions 
(10 mM and 1 M) and fitted to eq 9, using nonlinear regression.  
Figure 12 A-C shows an example of ethanol calibration time course (A) and 
calibration plots (B-C). The concentrations used correspond to: a):0.1 mM b):0.4 
mM c):0.6 mM d):1 mM e):2 mM f):4 mM g):6 mM h):10 mM i):20 mM j):30 mM 
k): 40 mM. Injections made to reach the smaller concentrations (0.01, 0.02 and 0.05 
mM) as well as those to reach the plateau of biosensor response (80 and 100 mM) 
were not included in Figure 12A  
Injections of 0.5 mM and 1 mM of AA were made in fresh PBS (Figure 35, Section 
4.8), in order to assess the blocking ability of the biosensor against the main 
interference species present in rat brain (Calia et al., 2009). All biosensors were 
calibrated immediately after their construction (day 0) as well as after 24 h (day 1). 
Among all studied designs, the four most promising biosensors were selected for a 
study of their stability over time (Sections 4.1.2 and 4.2.2). The criterion was based 
on their better ethanol sensitivity and AA shielding capability at day 1 relative to the 
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The study over time was carried out by means of full calibrations of ethanol and AA 
from day 2 up to day 28 after the manufacture, by evaluating the trend values of 
parameters such as KM, IMAX, linear region slope, AA blocking, LOD and LOQ. 
After the calibrations the biosensors were rinsed with deionized water and stored dry 
in a fridge at 4 °C. 
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3.8 Preparation and calibration of oxygen microsensors.  
 
The O2 microsensors (Bazzu et al, 2009) were made using Teflon-insulated silver 
wires (30 mm in length; i.d. 125 ?m) by modifying a previously described procedure 
developed in our laboratory (Migheli et al, 2008). Approximately 1 mm of the wire 
was exposed and inserted into a silica capillary tube (10 mm in length; i.d.) 180 ?m, 
Polymicro Technologies, Phoenix, AZ) partly filled with graphite-loaded (55% w/w) 
epoxy resin (Araldite-M, Sigma-Aldrich, Milan, Italy). A preliminary 180 ?m 
diameter carbon-composite disk electrode (area, 2.5 × 10-4 cm2) was fabricated by 
mixing 850 mg of graphite powder with 500 mg of Araldite-M and 200 mg of 
hardener, and filling the silica capillary tubing with the mixture. The silver wire 
guaranteed a good electrical contact. After 24 h at 40 °C, the shape of the working 
electrode (WE) was transformed from circular to conical (Figure 13A) using a high 
speed drill (Dremel 300) equipped with an aluminum oxide grinding wheel.  
The final O2 microsensors had a length of about 250 ?m, a surface approximately of 
1.5 × 10-3 cm2, and a tip <25 ?m, dimensions well below those associated with 
significant tissue trauma caused by the implantation of larger probes (Duff and 
O’Neill, 1994; Fumero et al., 1994). Cellulose nitrate treatment was performed by 
immersing the WE in the colloidal solution three times and drying it for 60 min after 
each coat at 40 °C.  
O2 reduction was experimentally demonstrated on the microsensor surface (Figure 
13B) starting from –350 mV vs Ag/AgCl, using cyclic voltammetry (CV37 
voltammograph, BAS, Bioanalytical Systems Inc., West Lafayette) with a scan rate 
of 25 mV/s. Constant potential amperometry (CPA) was used for in vitro and in vivo 
calibrations and experiments, fixing the O2 reduction potential at –400 mV vs 
Ag/AgCl reference electrode (Bazzu et al., 2009).  
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Figure 13 : Schematic (A1) and microphotograph (A2) of the conical oxygen microsensor 
developed and used in this study and its electrochemical characterization (B) (Bazzu et al., 
2009). 
No significant interference signals were observed on exposing the sensors to other 
electroactive molecules: ascorbic acid (AA); uric acid (UA); dopamine (DA); 3,4-
dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) present in the 
striatal extracellular fluid (Migheli et al., 2008), even at pharmacologically relevant 
concentrations (0.5 mM for AA, and up to 5 ?M for the other neurochemicals). 
Oxygen microsensors were calibrated by adding known volumes of a standard O2 
solution (100%) to nitrogen-saturated PBS in an air-tight electrochemical cell (Figure 
14), in order to obtain an oxygen concentration ranging from 0 to 260 ?M. A more 
accurate calibration was performed at low oxygen concentrations. 
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Figure 14 Picture of the apparatus used for calibrating O2 microsensors and to test the oxygen 
dependence of ethanol biosensors. 
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3.8.1 Oxygen dependence study setup 
 
The conical-shaped oxygen microsensor described above was used to monitor the 
dissolved oxygen in the electrochemical cell for the study of ethanol biosensors 
oxygen dependence. All the experiments were performed in a three-electrode air-
tight electrochemical cell. 
Due to the co-presence of three ethanol biosensors and one oxygen microsensor in 
the same cell, the application of two different potentials was required to allow 
oxygen reduction and H2O2 oxidation. Thus, the three ethanol biosensors were 
polarized at +0.7 V, while the oxygen microsensor was polarized at –0.4 V using a 
Ag/AgCl as RE. 
The protocol used in the biosensors oxygen-dependence study is shown on Table 1, 
while an example of calibration time course is shown in Figure 16.  
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Initially, the sensors were immersed in the cell containing 15 mM ethanol in a 
volume of 10 mL of PBS.  
When a stable baseline for both oxygen microsensor and ethanol biosensor was 
reached (about 1 hour), the cell was saturated with pure nitrogen (arrow a, Figure 
16), bubbled in directly from a cylinder (100% N2), using an appropriate apparatus of 
tubes and syringes (Figure 15, left). 
 
  
Figure 15 Syringes and tubes used to inject the different gas into the cell (left) and the pure O2 
saturated PBS syringe (right). 
 
When the sensors were polarized and had reached a stable baseline current, known 
aliquots of a 100% oxygen-saturated PBS solution containing 15 mM of ethanol 
were added (Figure 15, right), ranging from 0 (100% N2) to 260 ?M O2 (Table 1). In 
this way, the PBS volume in the cell passed from 10 mL up to 20 mL, but the ethanol 
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Figure 16: Biosensors oxygen dependence experiment. O2 current values are inverted. Arrows 
correspond to: a) 100% N2 bubbled into the cell b): 12.4 ?M O2 c): 23.6 ?M O2 d): 33.9 ?M O2 e): 
43.3 ?M O2 f): 52 ?M O2 g): 60 ?M O2 h): 130 ?M O2 and i): bubbling O2 (21%) j) stop bubbling 
260 ?M O2. 
 
The presence of the oxygen microsensor assessed the variation of the oxygen 
concentration in the electrochemical cell, as shown on Figure 16. Oxygen current 
values (red) were inverted for an easier graphical interpretation. When nitrogen was 
bubbled (arrow a, Figure 16), a decrease in sensor currents was observed, due to the 
decrease in oxygen tension and the absence AOx electron acceptor substrate. Then 
oxygen was added in the N2 saturated cell, and biosensor activity gradually increased 
(blue) as [O2] became higher. Tested oxygen concentrations were: b): 12.4 ?M c): 
23.6 ?M d): 33.9 ?M e): 43.3 ?M f): 52 ?M g): 60 ?M h): 130 ?M and i): 260 ?M. 
The last concentration was reached by bubbling air into the tight electrochemical cell 
(arrow i, Figure 16).  
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The limiting currents for both types of sensors were reached immediately after the 
bubbling was stopped (arrow j, Figure 16,), and reached approximately the same 
baseline values for the corresponding oxygen concentration. 
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3.9 pH and temperature dependence study setup 
 
Variation in pH values in the brain could affect ethanol biosensor performance. The 
optimum pH for the enzyme Alcohol Oxidase used in our study, extracted from 
Hansenula, ranges from 5.5 to 8.5, as previously described (Barsan and Brett, 2008). 
The influence of pH on biosensor activity was studied at room temperature, by 
preparing different PBS solutions ranging the pH from 6.0 up to 9.8. The tests were 
conducted on the more suitable biosensor design for in-vivo implantation, selected on 
the basis of the oxygen dependence results (see discussion on Sections 4.3 and 5.4). 
The study was carried out by injecting a fixed ethanol concentration (15 mM) in each 
pH sample (Rocchitta et al., 2012). The relative currents obtained from each 
experiment were then plotted, as shown in Figure 30 of Section 4.5. 
The temperature dependence was also determined for 15 mM EtOH at physiological 
pH (7.4) in a range between 20 and 40 oC (Figure 31, Section 4.6). 
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3.10 Biotelemetric device hardware 
 
The electronic circuit of the implantable biotelemetric device was built using surface 
mount components and comprised two different parts: the amperometric module and 
the microcontroller/transceiver module (Figure 17). 
.  
Figure 17 The biotelemetry system used in this study ((Rocchitta et al., 2012; Bazzu et al., 2009). 
 
The amperometric module (Figure 17) was made soldering a quad operational 
amplifier (OPA, MCP6044), a Zener diode (ZXRE4001), four resistors, and one 
capacitor on a 30 mm × 18 mm PCB.  
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Figure 18 Circuit diagram of the amperometric module made by soldering a quad-OPA 
integrated circuit, a zener diode, four resistors and one capacitor on a 30 mm × 18 mm PCB 
incorporated in a small plastic enclosure. A microcontroller-driven digital module, an AM radio 
transmitter and a lithium battery completed the miniaturized device weighing only 12.4 grams. 
A detailed explanation of how thecircuit works is provided in the text (Rocchitta et al., 2012; 
Bazzu et al., 2009). 
 
The MCP6044 can operate from a single-supply voltage with “rail-to-rail” inputs and 
outputs; it has been designed for micropower applications consuming only 600 nA 
per OPA with low input bias current (1 pA) and high input resistance (>1013D). The 
zener diode plays a pivotal role in the amperometric circuitry: as bandgap voltage 
reference, it generates a fixed voltage (1.22 V) consuming around 10 EA in virtue of 
a limiting resistance (150 k_). The non-inverting input of the potentiostat (OPA1) 
was grounded, resulting in a positive potential applied to the working electrode (WE) 
ranging from 0 V (GND) to 1.22 V. The inverting input of the potentiostat was 
directly connected to the reference electrode (RE) and its output wired to the 
auxiliary electrode (AE). This allows the implementation of a feedback circuit in 
which RE and AE potentials are maintained at the 2 same value as the non-inverting 
input (potentiostatic circuit). The buffered voltage divider, composed of two resistors 
(R1 and R2 in Figure 18) and the voltage follower (OPA2), generated the fixed 
potential (+700 mV vs GND) necessary to polarize the WE (ethanol biosensor).  
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The current-to-voltage (I/V) converter is a single-supply adaptation of a classic 
transimpedance amplifier (OPA3, Figure 18) and derived from previously published 
designs.1-5 The transfer function of the I/V converter is: 
Vout = –(IOx ・ R) + Vapp       (10) 
in which IOx is the current flowing through the WE, R is the feedback resistor and 
Vapp is the potential applied to the WE (vs GND). A maximum anodic current of 
about 40 nA can be read without saturation (Vapp = 0.7 V; R = 50 MD). A feedback 
resistor (Rf, Figure 18) with a capacitor in parallel (Cf) completes a low-pass filter 
with a cut-off frequency (Fcut-off) of 25 Hz. The value of Cf was calculated in 
Farads according to the equation: 
Cf = 1 / (Fcut-off • 2π • R)       (11) 
A dummy cell was made based on a previously published design for testing the 
amperometric module of the biotelemetric device before sensor calibration (Serra et 
al., 2007). The aim of the design was to devise a Thevenin current source which 
would reproduce the constant amperometric response of a true electrochemical cell. 
The voltage applied to the dummy cell was generated between the WE and RE/AE 
and is equal to the voltage difference between the above electrodes. The resulting 
currents were converted in an output voltage (Vout) as illustrated in Figure 18. Data 
obtained from electronics calibration were similar to those obtained in previous 
studies (Rocchitta et al., 2007; Calia et al., 2009; Bazzu et al., 2009). The PIC12F683 
(Arizona Microchip) is the heart of the digital module. This is a 8-bit CMOS IC with 
low power features equipped with internal 10 bit ADCs. The microcontroller unit 
(MCU) performed the A/D conversion of Vout and Vapp voltages. After the digital 
signal processing (DSP) of acquired raw data, a serial data packet was generated and 
sent to the 433.92 MHz Amplitude Modulation (AM) transmitter (RT4-433.92, 
Telecontrolli. IT). In conjunction with the MCU, this component allows the 
realization of a serial data transmitter working at a speed of 2400 baud. A short 
range, miniaturized “loop” antenna was designed and integrated into the PCB board 
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The in-circuit-serial-programming 3 (ICSP) bus provides the possibility of 
programming the MCU “on-board” in a few seconds. A 210 mA h, 3 V lithium coin 
battery (Maxell CR2032) provided the power to the biotelemetric device for up to 
three weeks of continuous transmission (0.067 Hz). A small plastic enclosure (32 × 
21 × 14 mm) completed the mountable device, weighing 12.4 g including battery. A 
RR3-433.92 module (Telecontrolli. IT) was selected as AM receiver and connected 
to a personal computer (PC) by means of a serial-to-universal serial bus (USB) 
converter (FTDI-FT232R-based module). 
3.10.1 Firmware and software 
 
The firmware to drive the PIC12F683 MCU was realized in Microchip assembly 
language (MPLAB) freely available from www.microchip.com. The program 
consisted of a timer-interrupt routine for digitizing analogue values (Vapp and Vout) 
at fixed time intervals. When the analogue signals were digitized, the hardware ADC 
resolution (10 bit) was improved following an oversampling and averaging method,1 
increasing the ADC resolution to 12 bits. The software, running on the PC under 
Windows XP Professional™ or Windows 7™, communicates through the USB. The 
graphic user interface was developed using Profilab ExpertR (version 4.0 from 
Abacom), whereas the dynamic link library (DLL) serial-data-parser was 
programmed in C (Dev-C++ ver. 4.9.9.2) (Rocchitta et al., 2012; Bazzu et al., 2009). 
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Male Sprague-Dawley rats (Charles Rivers, Milan, Italy), weighing 280–330 g, were 
used for in vivo experiments. The rats were maintained under standard animal care 
conditions (12 h / 12 h light/dark cycle, light on at 07.00 h; room temperature 21 °C), 
with food and water provided ad libitum. Prior to the start of any experimental 
procedure, the health of the animals was assessed according to published guidelines 
(Wolfensohn and Lloyd, 2003). All procedures were specifically licensed under the 
European Community directive 86/609 included in Decreto No. 116/1992 of the 
Italian Ministry of Public Health. 
3.11.1 Stereotaxic surgery and in vivo experimental 
procedures 
 
The alcohol biosensors, as well as the silver reference electrode (RE) and auxiliary 
electrode (AE) were implanted under chloral hydrate (400 mg kg–1 i.p.) anesthesia. 
For accurately implant the biosensors in the right nucleus accumbens (shell) of the 
rats, coordinates from the atlas of Paxinos and Watson were used: 
+1.7 A/P from the bregma 
–0.9 M/L from the dura 
–7.6 D /V from the dura. 
The reference and auxiliary electrodes were implanted in the left parietal cortex 
(Figure 19), and two screws were inserted in the skull for reinforcing the 
biotelemetric device adhesion. The “basement” portion of the device (without 
battery) was fixed to the skull using dental cement (Paladur, Heraeus Kulzer, 
GmbH), and the electrodes were connected and the skin was sutured (Figure 20A).  
A “dummy cover” was coupled to the “basement” to prevent its fouling. Body 
temperature during anesthesia was maintained at 37 °C by means of an isothermal 
heating pad.  
90 
 
Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
 
Figure 19 Photograph of the neurotaxic surgery for biosensors implantation 
 
 
Figure 20: How the animals appear immediately after the implant still anesthetized (A) and 
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After the surgery the animals were housed in large plastic bowls (45 cm diameter) 
and maintained in a temperature- and light-controlled environment, with food and 
water ad libitum. The in vivo experiments started 24 h after surgery (day 1), coupling 
the rats with the telemetric device (see Section 3.10 and Figure 17) and were 
performed maintaining the animals in their own bowl (Figure 20B). In this way, rat 
free movement is guaranteed, and handling and other forms of stress are significantly 
reduced (Bazzu et al., 2009; Calia et al., 2009). The alcohol biosensor was polarized 
at + 0.7 V and the telemetric signal recorded (see Section 4.7, Figure 34) until a 
stable baseline was obtained. In a control group of animals (n = 3) intra gastric (i.g.) 
ethanol (1 g kg–1) was administered 20 min after the intra peritoneal (i.p.) injection of 
saline (1.5 mL). Using a similar protocol, a selective inhibitor of alcohol 
dehydrogenase (as discussed in Section 1.2.1), ranitidine (30 mg kg–1 dissolved in 
1.5 mL of saline), was administered i.p. (El-Bakary et al., 2010) in a second group of 
rats (n = 3). The biosensor current was monitored for 2 hours after ethanol 
administration (see Section 4.7, Figure 34). 
3.11.2 Histology 
 
Following the experiments, an overdose of chloral hydrate (800 mg kg–1 i.p.) was 
used to sacrifice the rats. The location of biosensors was confirmed by post-mortem 
histology. Brains were fixed in formal saline, and 50 mm coronal sections made with 
a cryostat. The slices were stained with cresyl violet and examined under a 
microscope (data not shown). 
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3.12 Statistical Analysis 
 
Currents were expressed in nanoampere (nA) and given as baseline-subtracted values 
± standard error of the mean (nA or ∆nA ± SEM). The AA ∆I value represents the 
difference between the current resulting from the injection of 1 mM and 0.5 mM AA 
in the electrochemical cell (Ryan et al., 1997). The limit of detection (LOD, eq 12) 
and limit of quantification (LOQ, eq 13) were determined using a statistical method 
based on the standard deviation (σ) of the response and the linear region slope (LRS) 
of the calibration curve (www.ich.org , 2005). 
 
LOD = 3.3 σ / LRS      (12) 
LOQ = 10 σ / LRS      (13) 
 
Variations in hydrogen peroxide sensitivity were calculated as percentage changes 
compared to enzyme-free sensors responses (100%). Statistical significance (p 
values) between groups was evaluated using unpaired t-tests. Concentrations of 
dissolved O2 were expressed in micromoles per liter while the oxygen reduction 
current was expressed in nA ± SEM. The sign of the oxygen currents (cathodic) was 
inverted to improve the readability of these data. 
In vivo statistical significance between groups was evaluated by averaging signals at 
different times and calculating unpaired t-tests, as illustrated in Figure 34 of Section 
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4 - Results 
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4.1 Biosensors response to ethanol and ascorbic acid  
4.1.1 Comparison at day 1 
 
For each different amperometric biosensor design (n = 4 for each group) the 
sensitivity to ethanol and ascorbic acid at day 1 was compared in vitro, because day 1 
would be the critical time of the in vivo monitoring for the implanted biosensors. 
Ten different biosensor designs were characterizated in terms of the apparent 
Michaelis–Menten kinetic parameters (IMAX and KM, eq 9) and AA interference 
parameters (Tables 2). Ascorbic acid interference values are expressed as 1 mM AA 
limiting current and AA ?I, resulting from the difference in the measured current in 
the transition from 0.5 to 1 mM AA). Moreover, ethanol sensitivity of the ten 
different biosensor designs was analyzed in terms of linear region slope (LRS), LOD 
and LOQ (Tables 3, eqs 12 and 13). 
The basic design is named design 1: 
 
1 - Ptc/AOx10/PPD 
 
As schematically represented in Figure 8, the enzyme AOx (200U/mL) was loaded 
onto the bare metal by means of 10 dips into the enzymatic solution, being let dry 
between each dip (see dip-evaporation technique description, Section 3.4). Afterward 
it was coated with the PPD layer. Design 1 resulted in a very low response in terms 
of both IMAX (2.95 ± 0.75 nA, R2= 0.962), and LRS (0.05 ± 0.05 nA mM–1, R2= 
0.979), coupled with a high KM value (82 ± 10 mM); the response to 1 mM AA was 
1.90 ± 0.21 nA. 
 
In design 2, component disposition was inverted, and coated with PU: 
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PPD was electropolymerized on bare metal (see Section 3.2) and Alcohol Oxidase 
immobilized over the polymer by means of a 10 dip-evaporation sequence. Then, the 
sensors were dipped once in a 1% PU solution as a “containment net” (Figures 9-10).  
As shown on Tables 2 and 3, this change did not significantly increase the IMAX (3.84 
± 0.30 nA, R2= 0.993) and the LRS (0.032 ± 0.035 nA mM–1, R2= 0.994), as well as 
the KM (73 ± 12 mM). This design, however, showed one of the best shielding power 
against 1 mM AA (0.99 ± 0.02 nA, with a ∆I of 0.19 ± 0.01 nA). 
 
Next designs (3-5) were obtained by adding the enzyme stabilizer PEI to design 2. 
The sensors were alternatively dipped first in a 1% PEI solution, then into the AOx 
solution (Figure 10). Different number of dips in both enzyme stabilizer and Alcohol 
Oxidase solutions were tested.  
 
3 - Ptc/PPD/[PEI(1%)/AOx]5/PU(1%) 
4 - Ptc/PPD/[PEI(1%)/AOx]10/PU(1%) 
5 - Ptc/PPD/[PEI(1%)/AOx]15/PU(1%) 
 
This led to a quite large increase in IMAX, KM and slope relative to design 1 (Tables 2 
and 3). Increasing the number of PEI/AOx dips from 5 (design 3) to 10 (design 4) 
and 15 (design 5) resulted in a proportional increase in IMAX, KM and slope. As 
consequence of this, the most efficient loading of enzyme in these designs was 
considered the 15 dips one, and for which the response to 1 mM AA (and ∆I) was 
similar to design 2. 
 
In design 6, the main change on biosensor configuration was represented by the 
deposition of a mixed AOx+1% PEI solution (10 dips): 
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A partial precipitation of the enzyme in the solution was observed. No benefit in 
terms of biosensor performance was observed (Tables 2 and 3) relative to design 5 
where PEI and AOx were separately deposited (10 dips). 
 
 
Table 2: In vitro characterization of ten different biosensor designs at day 1 in terms of the 
apparent Michaelis–Menten kinetic parameters (eq 9) and AA interference parameters. The R2 
value (coefficient of determination) is a measure of the goodness-of-fit of the EtOH calibration 
data with eq 9. 
 
Due to the failure of this attempt, a new approach was investigated to obtain a better 
design. In particular the substitution of PEI with glycerol, also used as enzyme 
stabilizer in 1% solution (design 7, Figure 10). Again, we alternately dipped 10 times 
the sensors into the 1% glycerol solution and then in the Alcohol Oxidase solution.  
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This change caused a decrease in terms of IMAX (2.65 ± 0.25 nA, R2= 0.969) and LRS 
(0.023 ± 0.002 nA mM–1, R2= 0.907) while causing an increase in KM (76 ± 12 mM). 
AA blocking properties were basically unaffected (Tables 2 and 3). 
 
 
Table 3: In vitro ethanol sensitivity of ten different biosensor designs at day 1 in terms of  linear 
region slope (LRS), LOD and LOQ  
 
A further step in order to increase the performance obtained up to this stage was to 
include the two enzyme stabilizers together (Section 3.5). So, a 1% mixed solution of 
PEI and glycerol was deposited over the nanometer thick layer of PPD. For design 8 
the sensors where alternately dipped 10 times, firstly in the enzyme stabilizers mix 
solution, and then in the 200 U/mL AOx solution. This multilayers pattern, 
represented in Figure 10 was trapped by mean of a quick dip into a 1% PU solution 
deposited by dip-evaporation: 
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The mix of PEI and glycerol led to a very remarkable enhancement of biosensors 
performance, resulting in a significant increase in IMAX (115 ± 6 nA, R2= 0.978), LRS 
(1.73 ± 0.08 nA mM–1, R2= 0.996) and KM (41 ± 5 mM) compared to the best designs 
obtained up to this stage (designs 4 and 5) with PEI alone (Tables 2).  
The response to AA was similar to other designs (Table 3), with shielding properties 
for 1 mM AA (1.72 ± 0.36 nA and a ∆I of 0.55 ± 0.12 nA). 
 
Designs 9 and 10 maintain basically the same scheme as designs 4 and 8, except for 
the substitution of PU with BSA cross-linked with GA as the “containment net” 
(Figure 11): 
 
9 - Ptc/PPD/[PEI(1%)/AOx]10/BSA(10%)/GA(1%) 
10 - Ptc/PPD/[{PEI(1%)+Glyc(1%)}/AOx]10/BSA(10%)/GA(1%) 
 
Although having the new well-performing mix of enzyme stabilizers, design 10 did 
not reproduce the very good results of design 8. It is possible that the addition of the 
protein BSA reduced the enzymatic activity, as well as the process of cross-linking 
by GA could inactivate AOx, reducing the number of active enzymes molecules. 
The results for designs 9 and 10 shown in Tables 2 and 3 are comparable with design 
5 in terms of KM and LRS, while producing a slightly higher IMAX and a lower 
response to AA interference. 
 
As for the apparent enzymatic kinetic values, biosensor response in terms of limits of 
sensitivity was also tested at day 1. The LOD and LOQ values (eqs 12 and 13) are 
shown in Table 3. 
The first design of biosensor that we have characterized (design 1) had a LOD of 2.7 
± 1.1 mM and a LOQ of 8.1 ± 3.3 mM. Design 2 showed similar values despite a 
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The introduction of PEI (designs 3–5) led to an increase in ethanol sensitivity. Data 
showed a proportionality between the number of dips in PEI and AOx solution and 
the sensitivity, passing from 5 to 15 dips. The higher concentration of enzyme 
deposited on the biosensor considerably reduced the LOD and LOQ down to 182 ± 
62 µM and 551 ± 186 µM, respectively (design 5). This result can be quantified as a 
decrease of the LOD value of –38 ± 5 µM per dip (R2 = 0.980, n = 4) and an increase 
in the LRS (+44 ± 5 pA mM–1 per dip; R2 = 0.989, n = 4), as shown in Table 3.  
Mixing PEI and Alcohol Oxidase together as in design 6 and the deposition of 
glycerol instead of PEI in design 7 led to a worsening in biosensor’ sensitivity. In 
fact, the limits of detection and quantification increased (Table 3) when compared 
with designs where PEI was immobilized alone, as in design 4 (10 dips) and design 5 
(15 dips). The best results in terms of sensitivity values were obtained by dipping the 
sensors of design 8 in the 1% mix solution of PEI and glycerol. This strategy of 
immobilization yielded the best design of biosensor, providing a consistent increase 
in ethanol sensitivity demonstrated by the lowest values observed for LOD (88 ± 28 
µM) and LOQ (265 ± 86 µM, Table 3).  
Finally, investigating the effect of substitution BSA cross-linked with GA instead of 
the 1% PU solution as “containing net” (designs 9 and 10), a doubling of LOD and 
LOQ values was observed, comparing the corresponding data from designs 4 and 8. 
The possible causes of this behavior have been discussed above. 
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4.1.2 Study of biosensor stability over time 
 
The stability of biosensors performance over time was determined through a study on 
aging. Among all the 10 designs developed in the first part of the study, the 4 more 
promising designs were selected, on the basis of their best values of apparent 
enzymatic kinetic parameters, sensitivity and AA shielding properties shown at day 1 
(Tables 2 and 3 Section 4.1.1).  
For that purpose, biosensors that were calibrated immediately after their manufacture 
on day 0 (corresponding to the time of in vivo implantation), and at days 1–2 (which 
represent the first and second day of data recording) were then further calibrated 
once at week (day 7, day 14, day 21) up to day 28. The purpose of this experiment 
was to know the temporal limit of each biosensor design for a reliable in vivo use, 
investigating the stability of the enzymatic activity and polymer shielding efficacy 
before biosensor performances decrease. 
 
Thus, ethanol and ascorbic biosensor response was assessed every 7 days, and 
Michaelis–Menten kinetic parameters IMAX (Figure 21) and KM (Figure 23) 
sensitivity (LRS, Figure 22), as well as the shielding power against AA (Figure 24) 
were analyzed.  
After each calibration, biosensors were rinsed with deionized water and then stored 
dry in a fridge at temperature of 4 oC. 
The four selected designs were: 
 
5 - Ptc/PPD/[PEI(1%)/AOx]15/PU(1%) 
8 - Ptc/PPD/[{PEI(1%)+Glyc(1%)}/AOx]10/PU(1%) 
9 - Ptc/PPD/[PEI(1%)/AOx]10/BSA(10%)/GA(1%) 
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The trend for these four selected designs was a quite homogeneous decay in terms of 
IMAX (Figure 21) and LRS (Figure 22) as biosensors got older. An interesting 
difference was evidenced in design 8. Until the seventh day after its manufacture, 
design-8 IMAX and LRS values were statistically superior with respect to the other 
designs. After this time the performances decreased, showing an analog trend 
compared with the other designs, up to day 28 (* = p < 0.05 vs. other designs on the 
same day (unpaired t-test). # = p < 0.05 vs. days 0–7 (ANOVA followed by 
Newman-Keuls post test). 
 
Figure 21 Aging (28-day in vitro study) of the four most promising biosensor designs (n = 4 for 
each group) for IMAX. * = p < 0.05 vs. other designs on the same day (unpaired t-test). # = p < 
0.05 vs. days 0–7 (ANOVA followed by Newman-Keuls post test). 
 
Designs 9 and 10 showed basically the same results from day 0 to day 7 (Figures 21 
and 22), even if lower than design 8. As already discussed, the difference in the 
“trapping net” deeply differentiated their behavior. 
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Figure 22: Aging for LRS. * = p < 0.05 vs. other designs on the same day (unpaired t-test). # = p 
< 0.05 vs. days 0–7 (ANOVA followed by Newman-Keuls post test).  
 
Design 5 demonstrated the worst performances, early decreasing in sensibility at day 
1 and day 2. Nevertheless, values obtained at day 28 were similar to the others. The 
main difference between designs 5 and 8 was the co-presence of glycerol in the 
mixed enzyme enhancer solution in the more performing design versus PEI alone in 
design 5, which clearly played an important role in design 8 performances. 
 
The trend in KM values showed a rather uniform behavior in all studied designs 
(Figure 23). The values of this enzymatic kinetic parameter increased from day 0 to 
day 2 for all biosensors, and then remained quite stable until the end of the study. 
The KM values of design 8 were the lowest, meaning that the substrate had a higher 
affinity for the enzyme, resulting in a faster turnover of ethanol molecules catalyzed 
by each protein. As a consequence, design 8 showed the best IMAX and LRS values 
discussed above (Figures 21 and 22). 
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Figure 23: Aging for KM. * = p < 0.05 vs. other designs on the same day (unpaired t-test). # = p < 
0.05 vs. days 0–7 (ANOVA followed by Newman-Keuls post test). 
 
Otherwise, the shielding efficacy for the ascorbic acid was quite different, depending 
on the structure of the considered design, even if basically they are all based on the 
same strategy of electro-deposition of the PPD polymeric layer. 
 
A very important parameter in the aging biosensor study is the PPD polymer 
effectiveness over time. In a multilayer, pattern-based biosensor, AA shielding 
efficacy could even be affected by the different components added over the PPD 
coating. Once again it seemed to be that the BSA-GA cross linking contributed to a 
deterioration of designs 9 and 10. As a matter of fact, those designs showed the worst 
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On the other hand, the final quick dip in the 1% PU solution (strong THF solvent, see 
Section 3.1) did not affect the PPD polymer consistency, and guaranteed a better AA 
interference rejection over the first week for both designs 5 and 8. From day 7 up to 
day 28, the biosensors ability to prevent AA interference decreased. This suggested 
that one week was the limit of reliability of the biosensor for in vivo implantation. 
 
 
Figure 24: Aging for AA ?I. * = p < 0.05 vs. other designs on the same day (unpaired t-test). # = 
p < 0.05 vs. days 0–7 (ANOVA followed by Newman-Keuls post test). 
 
This finding has been confirmed by calculating the AA percentage interference on 
the 30 mM EtOH current (i.e., in the linear response region). The evidence that 
ethanol could reach a concentration of about 30 mM in the CNS after intraperitoneal 
injection (Adalsteinsson et al., 2006; Jamal et al., 2003) led us to monitor the 
response of the selected designs (5, 8, 9 and 10) when exposed to that concentration 
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Figure 25 shows the limiting currents values for 30 mM EtOH detected for each 
different design. Furthermore, the AA ∆I currents studied over 28 days were plotted. 
The trend of IMAX  and LRS values discussed above for the stability study of design 8 
(Figures 21 and 22), together with the best AA rejection property, resulted in 
interference equivalent to only 1% after 2 days, which increased to just 2% at day 7 
(*, # = p < 0.05 vs. the corresponding day 0 (ANOVA followed by Newman-Keuls 
post test). 
 
In fact, by observing the limiting currents resulting from the oxidation of 30 mM 
ethanol, and the shielding power for ascorbic acid (AA ∆I), design 8 showed once 
again the best range of performance. 
 
 
Figure 25: Evolution over 28 days of the in vitro ethanol response (30 mM) and AA interference 
(0.5→ 1 mM ?I) of the four most promising biosensor designs. 
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4.2 Effects of enzyme loading on biosensor performance 
 
Based on the findings that design 8 was demonstrated to be the best performing and 
stable biosensor among all those developed, our study re-focused on investigating 
what the effects may be of depositing a different concentration of the enzyme AOx 
compared to the 200 U/mL solution used until this stage of the project. Thus, the 
only variable considered to further optimize the biosensor was to change the AOx 
solution concentration. Having established the benefits of design 8, however, the 
multilayered disposition of this configuration (see Figure 10, Section 3.6) was not 
varied, nor was the deposition sequence. 
 
In order to enhance ethanol biosensor performance and sensitivity, four fresh 
different AOx solutions were prepared, dissolving different amounts of enzyme in 1 
mL of PBS buffer: 
 
- AOx (100 U/mL) 
- AOx (400 U/mL) 
- AOx (600 U/mL) 
- AOx (800 U/mL) 
 
Then, AOx was deposited by dip-evaporation (10 quick dips) on the biosensor 
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Furthermore, because the enzymatic concentration variation is the core of this part of 
dissertation, it is opportune now to specify that design 8 will be named as “design 8-
200”, indicating the AOx concentration. Similarly, “design 8-100” and “design 8-
400” refers to the biosensors set obtained by 10 dips into the 100 and 400 U/mL AOx 
solutions, while “design 8-600” and “design 8-800” nomenclature will be use for 
biosensors made with the most concentrated enzymes solutions. 
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4.2.1 Comparison of new designs at day 1  
 
For the four new designs (n = 4 for each group), the sensitivity to ethanol and AA at 
day 0 and day 1 was assessed. These were then compared with results already 
obtained by design 8-200, in order to evaluate and quantify how the difference in 
AOx loading affected biosensor performance. In the same way, a study of their 
stability over time (day 0 to day 28) was conducted. 
 
The apparent Michaelis−Menten kinetic parameters (IMAX and KM) and the linear 
region slope (LRS) in the reference linear range were analyzed (Table 4), as well as 
LOD and LOQ values, and the efficiency in rejecting AA interference (Table 5). 
 
Table 4 shows the response parameters of the different designs at day 1. These data 
revealed that halving the enzyme concentration with respect to design 8-200 reduced 
the number of ethanol molecule oxidized at the biosensor surface per unit time, 
resulting in a lower IMAX (75 ± 6 nA) for design 8-100. On the other hand, when the 
AOx concentration was doubled (design 8-400), this led to higher IMAX values, equal 
to 308 ± 10 nA. 
So, IMAX values increased quite linearly with the augmentation of the enzyme loading 
from 100 to 200 and 400 U/mL solutions, ranging between 75 ± 6 and 308 ± 10 nA.  
This increase has been quantified as 0.80 ± 0.14 nA of limiting current for each unit 




Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
 
Table 4: In-vitro characterization at Day 1 (n = 4 for each group) of different biosensor designs 
with different enzyme loading 
 
When even higher concentrations of Alcohol Oxidase were used in the enzyme 
solution, as in designs 8-600 and 8-800, sensitivity decreased with respect to design 
8-400 and IMAX values tended to decay exponentially (R2 = 0.983; n = 4) with a 
halving of the current every 57 U/mL and a plateau of 44 ± 13 nA.  
This is unlikely due to fewer AOx molecules being deposited on the electrode 
surface, but could be partially related to the decrease in H2O2 sensitivity observed for 
these biosensors (see Table 5, and reactions 6–8 of Section 3.4). 
 
The LRS trend reflected that seen in IMAX. In fact, the LRS in the reference linear 
range also tended to increase with the concentration of enzyme in the dipping 
solution from designs 8-100 up to 8-400  (10 ± 2 pA mM–1 U–1 mL; R2 = 0.989; n = 
20), reaching the maximum value of 3.94 ± 0.12 nA mM–1. Again, a worsening in 
biosensors performance was found for designs 8-600 and 8-800, both relative to the 
original design (8-200) as well as to the best performing configuration at day 1, 
namely design 8-400 (Table 4). 
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Specifically, excessive levels of AOx in loading solution led to an exponential decay 
in ethanol sensitivity (R2 = 0.981; n = 20) with a halving of the resulting current 
every 56 U/mL of AOx and a plateau of 0.65 ± 0.15 nA mM–1.  
All the new designs showed the same linear response region (<KM) to ethanol as 
design 8-200, in a range between 0 and 40 mM. The only exception was design 8-
100 that showed a smaller linear response span (0–30 mM) because these biosensors 
exhibited the lowest apparent KM value, corresponding to 34 ± 7 mM (Table 4).  
Then passing from design 8-100 to design 8-400, a linear increase was observed in 
KM (0.074 ± 0.009 mM U–1 mL; R2 = 0.987; n = 20), whereas no significant 
differences were found for further increases in AOx solution concentration.  
 
 
The sensitivity parameters displayed by the four new designs were compared with 
design 8-200. Increasing enzyme concentration also influenced the LOD and LOQ 
(eqs 12-13, Section 3.12) as illustrated in Table 5. LOD values increased 
proportionally to the concentration of enzyme, ranging from 0.006 ± 0.004 mM 
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Table 5: In-vitro characterization at day 1 (n = 4 for each group) in terms of LOD and LOQ, 
H2O2 sensitivity decrease, and 1 mM AA interference. 
 
Hydrogen peroxide sensitivity (Table 5) decreased with solution enzyme 
concentration in a linear manner (–5.6 ± 0.4 % for every 100 U/mL increase of AOx 
in the dipping solution; R2 = 0.976; n = 20). Taken together, these results suggest 
that increasing the concentration of AOx in the dipping solution enhanced biosensor  
enzyme loading. The extra protein on the biosensor surface, however, progressively 
lowered the Pt sensitivity to H2O2, ultimately leading to lower EtOH responses (see 
reactions 6–8 of Section 3.4). 
Finally, no substantial difference among all the new designs at day 1 was found in 
terms of AA rejection (Table 5). As a matter of fact, the 1 mM limiting currents 
ranged from a minimum of 0.98 ± 0.27 nA (400 U/mL) to a maximum of 1.73 ± 0.13 
(200 U/mL).  
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4.2.2 Study of the new designs’ stability over time 
 
A study of biosensor stability over time was conducted for the new designs, 
monitoring the responses to ethanol and AA over a period of 28 days from their 
manufacture. Apparent Michaelis−Menten kinetic parameters (IMAX and KM) and 
LRS values determined for biosensors at day 2, day 7, day 14, day 21 and day 28 
were analyzed and compared to design 8-200 (as stated in Section 4.1.2), as well as 
LOD and LOQ values and the efficiency in rejecting AA interferences. 
All new designs showed a homogeneous decay in terms of IMAX (Figure 26) from day 
0 to day 28, and followed the same trend observed during design 8-200 aging study 
(see Figure 21). 
A significant improvement in terms of stability was shown by design 8-400; in fact, 
its better sensitivity and sensibility showed at day 1 was confirmed over time, 
resulting in higher IMAX values respect with the biosensor loaded with 200 U/mL. 
 
Figure 26: In-vitro stability study: evolution of the IMAX over a 28-day monitoring period for 
biosensors fabricated from different enzyme loading solutions (n = 4 for each group; * p < 0.05 
vs other groups). 
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Trends shown in Figure 26 illustrate how IMAX values of design 8-400 were 
statistically higher than for the others from day 0 to day 7 (p < 0.05 vs other designs), 
remaining superiors until day 21. Finally, at day 28, the gap between all designs 
tended to be smaller. 
The aging effect for design 8-600 and design 8-800 was quite different compared 
with the other configurations, in that they showed the worst performance at day 1, 
but the decrease in IMAX values was less pronounced over time. 
 
Mean values of KM were found to be not significantly dependent on enzyme loading 
up to 800 U/mL (Figure 27). KM values showed a rather homogeneous behavior for 
all designs over time, tending to slowly increase over the entire monitoring period. 
 
 
Figure 27: In-vitro stability study: evolution of KM over a 28-day monitoring period for 
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Figure 28 illustrates the trend of LRS values. It was observed to be similar to those 
previously described for IMAX. As a matter of fact, the LRS values of design 8-400 
biosensors were higher (* p < 0.05 vs other designs) than for other designs from day 
0 up to day 28. 
 
 
Figure 28 In-vitro stability study: evolution of the LRS over a 28-day monitoring period for 
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The biosensors effectiveness to reject AA interference was monitored throughout the 
aging study and expressed as AA ?I, as shown in Figure 29. 
Comparable values were obtained up to day 7 for all designs (0.47 ± 0.04 nA; n = 
20). Then, due to the deterioration of PPD polymer, a homogeneous increase in AA 
sensitivity was observed after day 7. The lowest observed slope belonged to design 
8-600 (0.21 ± 0.03 nA day–1), while the higher as been observed in design 8-100 
(0.34 ± 0.06 nA day–1).  
 
 
Figure 29. In-vitro stability study: evolution of the AA ?I, over a 28 days monitoring period for 
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4.3 Oxygen dependence of biosensor responses 
 
The oxygen dependence of the biosensor response to ethanol was tested for all 
designs. As shown in Table 6, oxygen IMAX increased almost linearly when higher 
concentrations of AOx solution were deposited on the biosensor surface, passing 
from design 8-100 (19.1 ± 3.5 nA) to design 8-200 (27.4 ± 3.5 nA) and design 8-400 
(64.2 ± 4.3 nA). The enhancement has been quantified as 0.16 ± 0.03 nA per each 
enzyme unit dissolved in PBS buffer ( R2 = 0.974; n = 20). 
For further increases of immobilized AOx molecules, IMAX values tended to 
exponentially decay (R2 = 0.924; n = 20) when the enzyme loading solution varied 
from 400 up to 800 U/mL with a halving of the current every 55 U/mL and a plateau 
of 13.4 ± 4.6 nA. 
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An increased oxygen dependence of the biosensor response, expressed as KM for O2, 
was observed for variation of AOx solution concentration from 100 to 400 U/mL, in 
parallel with IMAX (Table 6). In particular, design 8-200 oxygen dependence was 
quantified as 17.3 ± 4.4 µM, while design 8-400 showed a value of 37.7 ± 5.1 µM. 
Surprisingly, an opposite trend compared with what emerged from IMAX values was 
observed for further increases of AOx loading. As a matter of fact, oxygen 
dependence continued to increase for designs 8-600 and 8-800. Thus, a linear 
increase in oxygen dependence (KM(O2) = 0.091 ± 0.003 µM U–1 mL; R2 = 0.997; n 
= 20) was observed with the increase of the enzyme concentration in the loading 
solution from 100 to 800 U/mL. 
 
The results emerged from the oxygen dependence study were critical to establish 
which design among all those characterized was the most reliable for in vivo 
applications. The estimated average oxygen concentration dissolved in the 
extracellular fluids in the brain has been quantified as ~50 ?M from previous 
findings (Zauner et al., 1995; Murr et al., 1994; Nair et al., 1987). 
 
To monitor the variation in ethanol concentration in extracellular fluids, and 
particularly in the brain, independently from physiological oscillations in oxygen 
levels, the biosensor KM(O2) needs to be lower than one half of the oxygen 
concentration dissolved in the brain ECF. 
 
In this way, the biosensor would be saturated with oxygen, which is the electron 
acceptor involved in AOx catalysis (see reactions 6–8), so that ethanol oxidation 
would be based just on the apparent Michaelis–Menten parameters for ethanol. 
Design 8-400, while demonstrated to be more sensitive and stable up to 1 week 
among all designs developed, displayed an excessive oxygen dependence (KM(O2) = 
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On the other hand, design 8-100 and design 8-200 fulfill the KM(O2) requirement. 
Among these two designs, biosensors loaded with 200 U/mL AOx concentration was 
demonstrated here to be the best performing in terms of the analytically most 
important parameter (LRS)
 
on day 1, as well as of stability over time, and was 
therefore considered the most reliable design to monitor ethanol concentration in the 
brain for up to 7 days. 
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4.4 Biosensor response time 
 
Rapid detection is a critical characteristic for biosensors targeting molecules whose 
concentration could change rapidly, such as neurotransmitters and other biological 
compounds. As discussed in Section 1.5.3, a fast monitoring of ethanol brain level 
variations is a pivotal factor to better establish and understand the basis of its 
mechanism of action and its neurobiological effects on the CNS.  
 
For evaluating the response time of biosensors, ethanol and AA calibrations were 
performed in stirred condition, using a data acquisition rate of >100 Hz. A t90% 
parameter was previously defined (Rothwell et al., 2010) as the time needed for the 
signal to reach the 90% of its maximum response value, starting from its baseline 
current. 
 
In particular, we were interested to ascertain the response time for ethanol of design 
8-200 which, as previously discussed, showed the best performance of stability and 
sensitivity, being the most reliable candidate for use in in-vivo studies.  
 
The time required for design 8-200 to reach the t90% following the addition of ethanol 
aliquots in the electrochemical cell was quite fast (1.6 ± 0.7 s, n = 20; 4 biosensors × 
5 determinations; mean ± SD). This compares favourably with other PPD/PEI-based 
biosensor designs, such as that for glutamate of ~2 s (McMahon et al., 2007), and 
demonstrates one of the benefits of the ultra-thin nature of the PPD polymer–enzyme 
composite matrix. What is even more interesting is that the final layer of PU, not 
present in the 2007 design, did not increase the time response of these ethanol 
biosensors. 
 
This critical parameter suggests that design 8-200 was surely suitable for real-time 
monitoring of variations in ethanol concentration in brain extracellular fluids. 
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4.5 pH dependence of the biosensor response 
 
The final part of design 8-200 characterization consisted of the study of the pH 
influence on biosensor performance. The experiment was performed by addition of 
15 mM ethanol in each different pH solution tested, corresponding to the 
concentration could be reached in brain ECF after a single intra gastric 
administration of 1 g kg–1of ethanol (Rocchitta et al., 2012). 
 
 
Figure 30: The influence of pH on the 15 mM ethanol response of the design 8 biosensor. * p < 
0.05 vs pH 6.8 – 8.0. 
 
The biosensor response for 15 mM ethanol of design 8-200 after varying the pH from 
6.8 up to 9.8 is plotted in Figure 30. Results showed an increase in current signal 
passing from pH 6.8 to 8.6. The optimum in biosensor performance was obtained 
between pH 8.6 and 9.2, where the response was about 300% higher than at pH 7.4  
(p<0.05 vs pH 6.8 – 8.0). The response at pH 9.8 decreased, indicating no further 
improvement. Biosensor response at physiological pH 7.4 was considered adequate 
for in vivo studies. 
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4.6 Temperature dependence of the biosensor response 
 
Finally, a temperature dependence study on design 8-200 was conducted at 
physiological pH 7.4. Figure 31 shows the plot of biosensor response for 15 mM 
EtOH at different working temperatures. 
Although a small temperature dependence was observed, this was considerably less 
than that observed for the enzyme in solution (Kato et al., 1976). Specifically, the 
biosensor response was only 18% less at 20 oC compared with the maximum 
responses observed between 35 and 40 oC. Thus, the difference in oxygen demand at 
the two temperatures is not likely to have a major impact on the biosensors' oxygen 
tolerance in vivo (37 oC). 
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4.7 In vivo response of the biosensor to systemic 
administration of ethanol, and effect of ranitidine 
 
Biosensor design 8-200 was selected for implantation in the nucleus accumbens of 
Sprague-Dawley rats. New biosensors were freshly made and calibrated immediately 
before their implantation by means of stereotaxic neurosurgery. 
Figure 32 shows the result of in vitro calibration of ethanol biosensors at day 0 
before implantation. The resulting calibration curve showed reasonable Michaelis–
Menten kinetics (R2 = 0.965) with an IMAX of 126 ± 10 nA and a KM of 38 ± 7 mM (n 
= 4). The response to pharmacologically relevant concentrations of ethanol (0–40 
mM) revealed good linearity (R2 = 0.992) with a slope of 1.78 ± 0.44 nA mM–1.  
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In a separate series of experiments, the potential electrochemical interference of 
ranitidine was studied in vitro on a design 8-200 biosensor (indicated as “b”, red line, 
in Figure 33) and on an enzyme-free sentinel microsensor 
(Ptc/PPD/[PEI+Glyc]10/PU(1%) indicated as “s”, blue line in Figure 33. The aim of 
these experiments was to demonstrate that ranitidine, known to inhibit alcohol 
metabolizing enzymes (ADH, ALDH, MEOS as discussed in Section 1.2.1) does not 
interfere with immobilized AOx activity. Moreover, the test was required to exclude 
electroactive properties of the molecule at the concentrations used, because of 
ranitidine does cross the blood brain barrier in small quantities, estimated as 1–20 ng 
mL–1 (Walt et al., 1981). 
 
For this purpose, three successive injections of ethanol (10, 20 and 30 mM, red 
arrows 1 Figure 33) were made in PBS, succeeded by two injections of ranitidine 
hydrochloride (1 and 10 µM at green arrows 2 and 3, respectively). Results shown in 
Figure 33 demonstrated that ranitidine did not interfere with Alcohol Oxidase 
activity or exhibited any detectable electroactive properties (at +0.7 V vs. Ag/AgCl). 
Biosensors were also exposed to AA (0.5 mM and 1 mM) to confirm their AA 
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Figure 33: Tests of the potential electrochemical interference of ranitidine performed by two 
injections of ranitidine hydrochloride in the presence of a biosensor and ‘sentinel’ sensor. The 
potential interference of ranitidine was studied in vitro on a design 8-200 biosensor (indicated as 
“b”) and on an enzyme-free sentinel microsensor (Ptc/PPD/[PEI(1%)+Glyc(1%)]10/PU(1%), 
indicated as “s”) by means of three successive injections of ethanol (10, 20 and 30 mM, red 
arrows 1) were made in PBS succeeded by two injections of ranitidine hydrochloride (1 and 10 
µM, green arrows 2 and 3, respectively). 
 
The in vivo experiments started 24 h after surgery (day 1) by polarizing the ethanol 
biosensor at +0.7 V versus the implanted Ag/AgCl reference electrode, and recording 
the telemetric signal until a stable baseline was reached (by 40–50 min). 
The control group of animals (n = 3) was pretreated with an injection of saline 
solution (1.5 mL i.p; Figure 34, arrow 1). After 20 minutes, the ethanol was 
administered (1 g kg–1 i.g.; Figure 34, arrow 2) and resulted in an increase of the 
biosensor current that reached its maximum amplitude (23.4 ± 3.2 nA) about 30 
minutes after ethanol administration (i.e., at 60–80 min; see Section 1.2 for more 
informations about ethanol pharmacokynetics). The biosensor current was recorded 
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In a second group of rats (n = 3), ranitidine at dose of 30 mg kg–1 dissolved in 1.5 
mL of saline was administered i.p. 20 minutes before the intra-gastric administration 
of ethanol (arrow 1, Figure 34). 
 
 
Figure 34: In vivo response of ethanol biosensors implanted in the right nucleus 
accumbens 
 
The peak of biosensor current appeared about 30 minutes after ethanol 
administration, and maintained quite a high level (27.9 ± 4.3 nA at 60–80 min). As 
expected, due to the ranitidine effect on catabolic ethanol enzymes of rats, the 
subsequent decrease was less pronounced in ranitidine-pretreated animals (23.2 ± 3.5 
nA at 140–160 min) and statistically different from the control group (p < 0.05). 
Following the experiments, rats were sacrificed and post-mortem histology 
performed demonstrating that all biosensors were located in the shell of the nucleus 
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4.8 PPD polymer properties 
 
As stated in Section 3.3, a further investigation of polymer deposition strategies was 
conducted in a different experimental environment, carried out in the Biosensors & 
Electrochemistry Laboratory of the School of Chemistry & Chemical Biology at 
University College Dublin. 
The main purpose was to examine the behavior and the efficiency of the PPD 
polymer when the ortho-phenylenediamine monomer (weak base electrolyte) was 
dissolved in media other than PBS, which had been used up to this point in our 
laboratory in Sassari. For each monomer solution, the pH and conductivity (κ) 
parameters were checked immediately after the electropolymerization procedure. 
Electro-deposition conditions used in this study are shown in Table 7. 
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The highest pH value was obtained from the monomer solution made by dissolving 
300 mM oPD powder in MilliQ water (pH 7.65). The basicity of the oPD amine 
groups contribute to increase the alkalinity of the solution. For the same reason, the 
value of the same high concentration of oPD increased to pH 7.58 the normal value 
of the PBS buffer pH (7.4). The lowest pH value was obtained for 300 mM oPD 
dissolved in a100 mM HCl aqueous solution, pH 4.54, due to the amount of acid 
present. Then, three different monomer solutions were prepared, by dissolving 50, 
100 and 300 mM oPD in a 10 mM HCl aqueous solution. pH values progressed from 
5.20 to 5.51 and 5.88, respectively, when increasing the dissolved monomer 
concentration.  
Conductivity values (κ) ranged from 11 ?S cm−1 for 300 mM oPD dissolved in Milli-
Q water (illustrating the very weak nature of this electrolyte monomer) to 12.9 mS 
cm−1 when dissolving the monomer in PBS. This latter value was due to the higher 
ion concentration in PBS buffer compared with the other solutions (Table 7).  
The further analysis of electropolymerization values of Qpoly, t½(poly), Imax(AA) and 
tmax(AA) is shown in Table 8 (see Section 3.3 for further details).  
Qpoly values (the amount of charge passed during the 30 min of the 
electropolymerization procedure) did not show any particular trend or difference 
among the various polymers. 
Values of t½(poly), i.e., the half-life of the exponentially decaying 
electropolymerization current associated with the self-sealing electro-deposition of 
the insulating PPD layer, and therefore a measure of the time required by the 
polymer to form, was faster for monomer solutions containing high ion 
concentration. In particular, polymers made in PBS medium had a half-life of only 
0.35 ± 0.04 s (n=12) while, in contrast, the MilliQ water system needed 480 ± 60 s 
(n=16). For other polymers, the t½(poly) values were rather homogeneous, and not 
really useful in predicting permselectivity polymer properties. 
Values of Imax(AA) indicated the highest current (nA) reached by the sensors for 0.5 
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When this concentration was injected, the naive polymer experienced AA for the first 
time, and represents a basic model of biosensor implantation in the brain (Figure 35), 
where a baseline of 0.5 mM AA has been estimated (Miele and Fillenz, 1996; 
Boutelle et al., 1989; O'Neill and Fillenz, 1985). Thus, Imax(AA) was used as a 
predictive parameter of biosensors behaviour immediately following implantation, 
but not as discriminative value of the polymer’s effective shielding efficiency during 
LIVE (long-term in-vivo electrochemical) recordings. 
 
Figure 35: A typical AA time course. Blue arrow (a) indicates the flat baseline current reached 
by the biosensors following their immersion in PBS overnight. Red arrows correspond to the 
two injections of 100 mM AA stock solution needed to expose the biosensors to 0.5 mM (b) and 1 
mM AA. 
 
Although some Imax(AA) values were high compared with the 1 mM AA current (see 
Table 8), many PPD-coated sensor designs showed a progressive decrease in 0.5 mM 
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The best results in terms of Imax(AA) were provided by polymer made with 300 mM 
oPD solved in PBS (1.1 ± 0.1 nA, n=12). Nevertheless, the time needed to reach the 
peak of the current was long, because of the time course tended to widen over the 
calibration, as indicated by the tmax(AA) value in Table 8 (66 ± 9 min, n=12). In this 
way, the time required for the current to decrease and reach a 0.5 mM plateau was 
quite long (Figure 35). 
 
 
Table 8: Some PPD electropolymerization and AA calibration parameters 
 
On the other hand, even if polymer made by deposition in 10 mM HCl+300 mM oPD 
showed the highest Imax(AA) value (4.0 ± 0.5 nA, n=16) compared with PBS, the 
peak was reached in a shorter time (tmax(AA) = 34 ± 2 min, n=16), soon beginning to 
decrease and stabilizing its 0.5 AA limiting current (data not shown). The polymers 
electro-deposited in the presence of the lower oPD concentrations investigated (100 
and 50 mM) gave essentially the same results in terms of Imax(AA) value compared 
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The MilliQ Water+300 mM oPD polymer showed a Imax(AA) value of 6.0 ± 0.3 nA 
(n=16) and a tmax(AA) of 65 ± 8 min. Finally, the polymer made by deposition in 100 
mM HCl+300 mM oPD resulted in the worst Imax(AA) value and longest tmax(AA) 
values. 
Unlike the data discussed above, results obtained by evaluating the analytical 
performance of the different polymers studied represent the main discriminative data, 
indicating the apparent permeability and selectivity parameters of the novel 
polymers: P(HP)%, P(AA)% and S% (see Table 9). 
 
 
Table 9: apparent permeability parameters. Values of parameters are presented as mean ± 
standard error (SEM). All electropolymerization were performed at + 0.7 V vs a pseudo Ag 
reference electrode. 
 
Values obtained for the new polymers were compared with those from the classic 
medium commonly used for the polymer coating, or by dissolving 300 mM oPD in 
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PBS buffer, where the apparent permeability to hydrogen peroxide, P(HP)%, was 72 
± 11% (n=12). 
An improvement in hydrogen peroxide permeability was achieved by polymerizing 
the platinum wires with a 100 mM HCl+300 mM oPD solution (93 ± 5%; n=12). The 
difference in the slopes (nA mM-1) obtained for the hydrogen peroxide calibration 
performed before and after the polymer deposition was really marginal.  
 
A higher P(HP)% value respect to the PBS condition was also reached by 
polymerizing the sensors using a 10 mM HCl+300 mM solution, corresponding to 81 
± 4% (n=16), while no improvement was observed by electro-deposition in a 10 mM 
HCl 100 mM oPD solution. 
 
Comparable results of hydrogen peroxide permeability were obtained between 
polymers made of 50 mM oPD in 10 mM HCl (75 ± 5%) and the classic PBS+300 
mM oPD condition. No improvement was observed by dissolving 300 mM oPD into 
MilliQ water, not even with 10 mM HCl 100 mM oPD (46 ± 7% and 56 ± 5%, 
respectively, n=8). 
Because the incorporation of a permselective membrane such as PPD on the 
implantable biosensor surface is required to reject electrochemical interference by 
reducing agents present in the tissue (McMahon et al., 2006), the values of P(AA)% 
plays the very key role in determining what is the best performing polymer (O’Neill 
et al., 2008; Kirwan et al., 2007). The reference PBS conditions of deposition 
resulted in an excellent AA-rejection value of 0.15 ± 0.03% (n=12). The only 
improvement was seen following the electro-deposition procedure in the 10 mM 
HCl+300 mM oPD medium, leading to a value of 0.09 ± 0.02% (n=16). All the other 
polymers displayed a worsening in AA shielding efficiency, even the one obtained 
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Polymer selectivity (S%) defined by eq 5 (Section 3.3) represents the percentage 
interference by AA in H2O2 detection for equimolar concentrations, and for 
biosensor applications the ideal value would be zero (O’Neill et al., 2008; Kirwan et 
al.; 2007). 
By virtue of the good hydrogen peroxide permeability (81 ± 4%) and the excellent 
AA rejection properties (P(AA)%, 0.09 ± 0.02%), the polymer obtained by 
polymerizing at +0.7 V vs Ag in the 300 mM oPD monomer dissolved 10 mM HCl 
solution resulted in the best selectivity value (S%, 0.07 ± 0.02%, n=16). 
 
Surprisingly, wide variations in PPD electrosynthesis conditions only marginally 
affected the ability of this polymer to transport H2O2 to the metal surface, while 
demonstrating an efficient AA interference rejection. For example, even a three 
orders of magnitude difference in the half-life of the electropolymerization self-
sealing process observed between the pure water and PBS systems (Table 8), only 
gave rise to a factor of four difference in their resulting permselectivity (S%) values. 
Thus, the correspondent value of S% obtained by dissolving the monomer in PBS 
buffer was 0.17 ± 0.03% (n=12). This result revealed that the novel polymer 
improved the permselectivity by a factor of 2.4. 
All the other polymers investigated showed a poorer (higher) value of S% (Table 9). 
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Ethanol, is the main non-aqueous component of alcoholic drinks, whose 
consumption is a legal, commonly-accepted and widespread practice in nearly all 
societies, particularly in western cultures. As a consequence, alcohol is the most 
consumed psychoactive drug in the world, due to its abilities to change human 
consciousness and to its easy availability. 
 
Although there is evidence that a moderate consumption of ethanol could be helpful 
to the heart (Carrizzo et al., 2013; Tung et al., 2013), an unregulated use of alcohol is 
truly unsafe: its toxic action on organs, chiefly the liver, coupled with its teratogenic 
properties and psychoactive effects, make it a dangerous drug for human health. 
Alcohol is able to induce cirrhosis and steatosis (Fickert and Zatloukal, 2000), as 
well as pass through the placental barrier and inhibit fetal growth or weight, creating 
typical facial stigmata and a series of mental and physical damage, producing the so-
called fetal alcohol syndrome or FAS (Lemoine et al., 2003). 
Moreover, high levels of ethanol found in drivers’ blood is the major cause of death 
from car crashes, especially among young drivers (Voas et al., 2013; Voas and Fell, 
2013). 
 
Acute ethanol effects are due to its pharmacokinetic profiles of absorption, 
distribution and elimination which determine the level of systemic exposure. 
Ethanol crosses the blood–brain barrier and acts as a psychoactive drug primarily 
affecting brain functions altering perception, mood, consciousness, cognition, and 
behavior. Ethanol exerts a biphasic effect on the CNS, inducing prevalently euphoric 
effects at low doses, while depressing its function when BALs increase. 
 
Alcohol affects the physiological action of a wide range of brain neurotransmitters 
and signaling molecules.  
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Acute ethanol chiefly enhances inhibitory GABAergic transmission (binding to its 
specific site at GABA-A receptors, see Figure 3 in Section 1.3.1), and decreases 
glutamatergic excitatory systems leading to a general weakening of brain functions.  
The acute ethanol-derived increase of GABAergic transmission, together with the 
disruption of the glutamatergic tone in the CNS, are responsible for the euphoric, 
sedative, tranquilizing and anesthetic properties of beverage alcohol at low–medium 
concentrations (Lovinger et al., 1989). The dual effect of alcohol manifests when 
BALs increase further. The alteration of the glutamate system is responsible for 
staggering, slurred speech, and memory blackouts, while the further contribution of 
GABA effects, related to high ethanol doses, leads to a severe depressant effect on 
brain functionality, which in extreme cases can lead to loss of consciousness, coma 
and even death as a result of respiratory depression (De Witte, 2004). 
Moreover, alcohol affects the physiological action of other neurotransmitters and 
signaling molecules, such as dopamine, serotonin, opioids, acetylcholine, 
norepinephrine, neuropeptide Y, etc. 
 
In particular, opioid systems and serotonin appear to contribute to influence alcohol 
drinking behavior by interacting with the mesocorticolimbic dopaminergic system 
(Hyman et al., 2006; Janecka et al., 2004), a specific brain neuronal reward system 
which uses dopamine as neurotransmitter (see Figure 4 and Section 1.3.7 for further 
information) involved in movement, motivation, learning, arousal and orgasm, 
emotion and attention (Gonzales et al., 2004), and demonstrated to play a key role in 
modulating fundamental survival mechanism of species, such as how to obtain food, 
water or mating, defined as reward-motivated behaviors (Hyman et al., 2006). Both 
responses to natural rewards and various drugs of abuse have been found to show 
several similarities and shared pathways, increasing the level of released dopamine in 
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Ethanol acts in the same way, by promoting an increase of activity in the mesolimbic 
dopamine system (VTA) and of the multisynaptic dopaminergic reward circuitry, 
resulting (at least acutely) in higher levels of dopamine released in the neuronal 
dopaminergic projections, predominantly nucleus accumbens (Di Chiara and 
Imperato, 1986; Koob and Bloom. 1988). 
 
Thus, dopamine seems to play a very key role, being involved in those ethanol 
positive reinforcing properties demonstrated to be crucial in first stages of alcohol 
addiction. A sensitization phenomenon seems to be the first step leading a subject 
from alcohol use to abuse, due to an increment in the reinforcement value of ethanol 
after repeated exposure, when an individual associates the liking effects of alcohol 
with the positive stimulus of wanting (Robinson and Berridge, 1993). After repeated 
consumption of alcohol, the wanting is amplified into a pathological status 
characterized by craving for the drug. 
The continual consumption of ethanol can cause alcoholism, a severe pathological 
chronic relapsing disorder characterized by the high and compulsive ingestion of 
alcohol, and loss of control over intake (Section 1.4).  
The long-term abuse of alcohol produces physiological changes in the brain. The 
neurotransmitter systems disrupted by acute ethanol, such as those of GABA and 
glutamate, are even more deeply altered during chronic exposure, generating 
adaptive processes resulting in a compensatory balance that concur to develop 
neuroadaptive phenomena such as tolerance (Leblanc et al., 1975) and 
psychophysical dependence. This dysregulation also involves neural circuits 
implicated in the control of motivational processes (arousal, reward, stress, etc.), 
such as those involving serotonin, opioids and norepinephrine. The impairment of 
these systems deeply contributes to the allostatic state that characterizes the 
development of alcohol dependence (Hardman and Limbird, 2005; Volkow et al., 
2007), such as to the onset of withdrawal syndrome, the irrefutable signal of physical 
dependence characterized by a state of hyperexcitation, anxiety and delirium tremens 
(O’Brien, 2005; Sullivan et al., 1989).  
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In attempting to restore the “pathological neurotransmitter equilibrium” and avoid 
the negative psychophysical effects related to further withdrawal episodes (negative 
reinforcement; Rassnick et al., 1993), the addicted individual needs a continuous 
assumption of ethanol (Valenzuela and Harris, 1997).  
 
Although subjected to diverse studies, the molecular mechanisms through which 
ethanol alters the function of the mesolimbic dopamine system have still not been 
entirely elucidated (Karahanian et al., 2011; Mostofa et al., 2003; Munson et al., 
1995). Moreover, the varied and complicated set of interactions with several 
neuronal pathways makes the investigation of ethanol pharmacodynamics quite 
difficult. Several researchers focused their efforts to better understand the causes and 
the mechanisms involved in this very complex disorder, and even if much progress 
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5.2 Approaches to ethanol detection 
 
Ethanol detection in the brain kindles a particular interest, especially the monitoring 
of its concentration dynamics. New technologies are being combined with traditional 
approaches to study the effects of acute alcohol as well as the delicate transition from 
alcohol use and abuse to dependence. 
Using the most appropriate methods it is possible to investigate its effects on humans 
as well as in animal models which recreate the specific symptoms of alcohol 
dependence (Loos et al., 2013).  
Non-invasive approaches such as magnetic resonance spectroscopy (MRS), magnetic 
resonance imaging (MRI) or positron emission tomography (PET) have been used to 
monitor directly alcohol and its metabolites, in the CNS of both animals and humans 
(Adalsteinsson et al., 2006; Ross and Bluml, 2001; Sammi et al., 2000; Hetherington 
et al., 1999; Mushahwar and Koeppe,1972), while microdialysis demonstrated to be a 
reliable technique in preclinical studies to investigate the relationship between 
ethanol-related behaviors and neurochemical variations (Gonzales et al., 1998) and to 
assess the effects of some therapies for alcoholism (Nurmi et al., 1994). 
 
Nevertheless, all the above-cited techniques possess temporal resolution and 
detection limits (see Sections 1.5.1–1.5.2 for a further detailed description), yet 
ethanol concentrations in the brain can vary dynamically, as well as those of the 
neurotransmitters it affects. As a consequence, their optimal study would require a 
real-time approach, such as the employment of a biosensing technique, which has 
already been demonstrated to be a reliable tool in the dynamic detection of a number 
of neurobiological molecules, with high temporal and spatial resolution (Rocchitta et 
al., 2013; Secchi et al., 2013; Rocchitta et al., 2012; Mohd Zain et al., 2012; Calia et 
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The desire for monitoring of fast ethanol concentration dynamics focused our 
research to develop, characterize and optimize an implantable amperometric 
biosensor capable of real-time monitoring ethanol concentration changes in brain 
extracellular fluids of animals (Secchi et al., 2013; Rocchitta et al., 2012). 
 
A biosensor is an analytical tool in the form of a self-contained integrated device 
which is capable of providing a specific, often quantitative, measure of the 
concentration of a target substrate, using a biological recognition element, usually an 
enzyme, which is in direct spatial contact with a suitable transducer element (see 
Section 1.5.3 for a more detailed description). 
The flavoprotein Alcohol Oxidase from Hansenula polymorpha was chosen as 
biological element to develop our ethanol biosensor (Sections 1.5.3.2 and 3.4). This 
aspecific enzyme converts ethanol into acetaldehyde and hydrogen peroxide as a by-
product. Then, hydrogen peroxide was oxidized at the Pt transducer surface, by 
applying a constant anodic potential of +0.7 V vs Ag/AgCl, producing a detectable 
electric current related to ethanol concentration (eqs 6-8 in Section 3.4). Based on the 
mechanism of how the response is generated, this amperometric ethanol biosensor 
belongs to the first-generation biosensor category, as discussed in Section 1.5.3. 
Five different enzyme solutions were prepared by dissolving the enzyme powder in 1 
mL of PBS buffer (Phosphate Buffered Saline), and the concentration expressed as 
units of protein dissolved per mL, specifically 100, 200, 400, 600 and 800 U/mL. 
Nevertheless, in the first phase of biosensor development only the 200 U/mL 
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5.3 Ethanol biosensor characterization 
 
Ten different miniaturized ethanol biosensor designs were initially developed, all 
based on the same cylindrical geometry, obtained by cutting away 1 mm of Teflon 
coating the micrometer (125 ?m) Pt wire transducer (Figure 7 in Section 3.4). 
The different strategies used to differentiate biosensor designs involved the variation 
of the sequence of PPD electrodeposition and of enzyme immobilization, as well as 
changes in the amount of enzyme loaded (Section 4.2), the addition or co-addition of 
enzyme stabilizers (Section 3.5), as well as their disposition in the multi-layered 
pattern (Section 3.6, Figures 8-11). All these approaches aimed to obtain the best 
performing design, maximizing ethanol sensitivity as well as the biosensor ability to 
reject the main electroactive interference species present in the brain, chiefly AA. 
Because of the electro-deposition of a poly-ortho-phenylenediamine (PPD, described 
in Section 3.2) nanometer-thick membrane has proven to be a reliable procedure to 
drastically limit the passage of AA trough the biosensor component layers, allowing 
simultaneously a good hydrogen peroxide permselectivity (Kirwan et al., 2007), all 
designs manufactured were based on this strategy for blocking interference species 
(Secchi et al., 2013; Rocchitta et al., 2012). 
 
Immediately after the manufacture, all biosensors were characterized in vitro in an 
electrochemical cell (Section 3.7) at day 0, corresponding to the time of in vivo 
implantation, and at days 1-2, which represent the first and second day of in vivo data 
recording. 
Among these ten designs, the four most promising biosensors (5,7,8 and 10; see 
Tables 2 and 3) were further calibrated once at week (day 7, day 14, day 21) up to 
day 28 to know the temporal limit of each biosensor design for a reliable in vivo use, 
investigating the stability of the enzymatic activity and polymer shielding efficacy 
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Ethanol and AA calibrations were performed using CPA technique (see Section 
1.5.3.1) and biosensors performance analyzed in terms of IMAX, KM, LRS and AA 
shielding power (eq.9, Section 3.4) as well as by evaluating LOD and LOD values 
(eqs 12 and 13). These are fundamental parameters in order to evaluate the 
sensitivity to ethanol versus interference species (O’Neill et al, 2008), and are critical 
to select the best performing design for in vivo implantation (Secchi et al., 2013; 
Rocchitta et al., 2012). 
 
The first step was to establish the best strategy to immobilize the enzyme relative to 
PPD polymer deposition, in order to achieve the highest number of active AOx 
molecules on the biosensor surface. 
The amount of active enzyme on related biosensor surfaces is quantified by IMAX 
parameter (eq 9), provided the sensitivity of the biosensor to the hydrogen peroxide 
is similar across the designs (Kirwan et al., 2007; Rothwell et al., 2010). 
Comparison of results obtained at day 1 shows that the first biosensor developed 
(design 1) had the worst sensitivity (Tables 2-3, Section 4.1.1). Evidently, 
immobilization of the enzyme on the metal bare and the electropolymerization of 
PPD over the biological component layer was not advantageous (Figure 8).  
 
As shown in Table 2, an increase in IMAX was observed in design 2, where PPD was 
directly deposited on the transducer surface while Alcohol Oxidase was immobilized 
over the PPD nanometer-thick layer. Moreover, 1% PU was introduced as a 
“trapping net” (Figure 9). 
The further addition of PEI (Figure 10) led to an increase in biosensor IMAX value, 
compared with both designs 1 and 2 (Table 2). PEI is a positively-charged 
macromolecule usually known to act as an enzyme stabilizer (Bolivar et al., 2009; 
Qian et al., 2004) that interacts with the negative charges of the oxidase enzymes (at 
pH 7.4), enhancing their catalytic activity (Section 3.5). However, in our study, PEI 
acted more as an “enzyme activity enhancer”, as previously described (Secchi et al., 
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On the other hand, the presence of glycerol gave greater stability to the biosensor. 
Then, mixing together both PEI and glycerol (1% solution), we obtained an additive 
effect evidenced by the increased number of active enzyme molecules demonstrated 
by the enhanced IMAX and decrease of LOD and LOQ values (Tables 2 and 3) and by 
the maintenance of such high IMAX and values over time (Figures 21, Section 4.1.2) 
due to the glycerol effect in designs 7, 8 and 10 (Rocchitta et al., 2012). 
 
The second apparent Michaelis–Menten parameter, KM, is the substrate concentration 
corresponding to the half of IMAX response, and reflects both the affinity and access 
of the substrate to the enzyme (Moran et al., 2005). 
This parameter plays a dual significance in analyzing biosensors performance: it 
determines the amplitude of linear region slope of the biosensor substrate (LRS = 
IMAX / KM), as well as the concentration range of the linear response (~½KM) (Bazzu 
et al., 2009; Kirwan et al., 2007). Thus, the higher the KM value, the smaller the LRS 
but the wider the linear response region (Rocchitta et al., 2012). 
Due to the findings that ethanol in rats CNS could reach a concentration of 30 mM 
after 1 g/kg i.p. injection (Yoshimoto and Komura. 1993; Adalsteinsson et al., 2006), 
corresponding to the dose and route of administration we wanted to use in our in vivo 
experiments, all the approaches were aimed to achieve the best IMAX and KM values, 
in order to obtain the highest ethanol LRS up to 30 mM (Rocchitta et al., 2013). 
The KM values of design 8 were the lowest, meaning that the substrate had a higher 
affinity for the enzyme, resulting in a faster turnover of ethanol molecules catalyzed 
by each protein. 
Thus, the introduction of the enzyme enhancer PEI provided a sustained increase in 
LRS values. Even though LRS is generally valid only up to half the KM value 
(Kirwan et al., 2007; Rothwell et al.; 2010) design 8 showed a good linearity up to 40 
mM with R2 = 0.996 (Table 3 ) because of slight deviations from Michaelis–Menten 
behavior (R2 < 0.98, Table 2) in the form of a flattening of the calibration plot at low 
concentrations (see Figures 12A-C and 32). Moreover, due also to the glycerol effect, 
design 8 IMAX and LRS values were statistically superior respect to the other designs 
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until the seventh day after its manufacture, as discussed in Section 4.1.2 and shown 
in Figures 21-22. 
Although having the same mix of enzyme stabilizers (PEI+Gly, 1%), design 10 did 
not reproduce the very good results of design 8. It is possible that the addition of the 
protein BSA reduced the enzymatic activity, as well as the process of cross-linking 
by GA could inactivate AOx, reducing the number of active molecules. 
 
As described before, following the failure shown by PPD coating procedure used for 
design 1, the common strategy used for blocking electroactive species was the 
electrodeposition of a PPD polymeric layer onto the bare metal surface. 
Nevertheless, the shielding efficacy for AA among all the sensors was quite 
different, depending on the structure of the particular design, ranging from 0.8 up to 
2.6 nA at day 1 (Table 3 on Section 4.1.1). 
The gap improved during the study of PPD polymer effectiveness over time. In a 
multilayer, pattern-based biosensor, AA shielding efficacy could even be affected by 
the different components added over the PPD coating. The final quick dip in the 1% 
PU solution (strong THF solvent, see Section 3.1) did not affect the PPD polymer 
consistency, and guaranteed a better AA interference rejection over the first week for 
both designs 5 and 8, while on the other hand it seemed to be that the BSA-GA cross 
linking contributed to a deterioration of designs 9 and 10, which showed the worst 
capacity in AA shielding (Figure 24 in Section 4.1.2). This suggested that one week 
was the limit of reliability of those biosensor for in vivo implantation. 
Furthermore, no significant interference signals were observed on exposing 
biosensors to other electroactive molecules (dopamine, 3,4-dihydroxyphenylacetic 
acid, and uric acid) present in the CNS extracellular fluids, even at 
pharmacologically relevant concentrations (data not shown), as reported previously 
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Indeed, another important parameter was determined from calibration data obtained 
from EtOH and AA responses over time. 
 
Because evidence in literature suggests that ethanol could reach a concentration of 
about 30 mM in the CNS after intraperitoneal injection (Adalsteinsson et al., 2006; 
Jamal et al., 2003) as well as its administration i.p. can increase AA levels (about 0.5 
mM) by about 200% in the striatum (Liu et al., 1999; Hou et al., 2005; Hou et al., 
2007; Dai et al., 2006), we decided to quantify the percentage interference by AA 
relative to the measured biosensor current for 30 mM ethanol. 
Although the response of AA in some brain areas, such as the hippocampus, can be 
markedly different from that in the striatum (Grünewald et al., 1983), AA baseline 
levels and responses in the striatum and nucleus accumbens are often quite similar 
(Brose et al., 1989; Fillenz and O'Neill RD. 1986). This knowledge of AA levels is 
important in which nucleus accumbens is the brain area where our ethanol biosensor 
would be implanted, being this neuronal termination widely accepted to be the 
epicenter of reward in the brain and where higher levels of dopamine are released 
after ethanol intake (Di Chiara and Imperato, 1986; Koob and Bloom, 1988). 
Moreover, as discussed above and widely in Sections 1.3.7 and 1.4, the nucleus 
accumbens is involved in those ethanol positive reinforcing properties and 
sensitization phenomenon demonstrated to be crucial in first stages of alcohol 
addiction (Robinson and Berridge, 1993), as well as in the pathological status 
characterized by craving for the drug (Gilpin and Koob, 2008).  
 
So, variations in the AA current when its concentration changed from 0.5 (striatal 
and nucleus accumbes ECF baseline level) to 1 mM where evaluated, expressed in 
nA as AA ?I. The impact of AA ?I on the current resulting from 30 mM ethanol is 
shown in Figure 25. 
For design 8, the percentage interference was estimated to be less than 1% up to day 
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Then it reached a value of 25% at day 14, increasing week by week in conjunction 
with the worsening of polymer shielding ability (Rocchitta et al., 2012). 
These results confirmed that design 8 could not be implanted for more than one week 
because of the decrease in its sensitivity (worsening of IMAX and LRS values) and 
selectivity, associated with the increase in AA interference (Secchi et al., 2013; 
Rocchitta et al., 2012).  
Nevertheless, these data also assessed that the predictable variations in AA 
concentrations in vivo in our target CNS area are unable to interfere significantly 
with the currents produced by 30 mM ethanol during the first 7 days in design 8, 
confirming that the best biosensor design developed among the ten original designs 
could be a reliable tool for short-time monitoring of ethanol in vivo (see Section 4.1.2 
for all detailed results and comparison among the different designs). 
 
Based on the findings that design 8 was demonstrated to be the best performing and 
stable biosensor among all those developed, our study re-focused on investigating 
what the effects might be of depositing a different concentration of the enzyme AOx 
compared to the 200 U/mL solution used until this stage of the project (see Section 
4.2 and subheadings, and Secchi et al., 2013; Rocchitta et al., 2012). 
 
Our goal was to achieve an improvement of active enzyme loading on the biosensor 
surface, in order to obtain higher IMAX values, as well as to extend its stability over 
time, decisive in evaluating the limit of in vivo reliable use ascertained as 7 days for 
design 8. 
Having established the benefits of design 8, however, the multilayered disposition of 
this configuration (see Figure 10, Section 3.6) was not varied, nor was the deposition 
sequence; at this stage, the only variable considered to further optimize the biosensor 
was to change the Alcohol Oxidase solution concentration. Four fresh different 
Alcohol Oxidase solutions were prepared, dissolving respectively 100, 400, 600 and 
800 enzyme units in 1 mL of PBS buffer in order to enhance ethanol biosensor 
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Thus, four new ethanol biosensor designs were generated by dip-evaporation into the 
fresh solutions. Because the enzymatic concentration variation of these different 
designs 8 assumed a critical relevance, it is necessary now to specify it for each of 
design 8. So, the original design 8 was re-named as “design 8-200”, indicating the 
AOx concentration of 200 U/mL. Similarly, “design 8-100” refers to the biosensor 
set obtained by 10 dips into the 100 U/mL AOx solution, as well as “design 8-400”, 
“design 8-600” and “design 8-800” nomenclature will be used for biosensors made 
with the most concentrated enzymes solutions, as described on Section 4.2. 
 
For the four new designs (n = 4 for each group), the sensitivity to ethanol and AA at 
day 0 and days 1-2 was assessed. In the same way, a study of their stability over time 
(day 0 to day 28) was conducted, by analyzing the apparent Michaelis−Menten 
kinetic parameters (IMAX and KM) and the linear region slope (LRS) in the reference 
linear range (Table 4), as well as LOD and LOQ values, and the efficiency in 
rejecting AA interference (Table 5). Results were then compared with results already 
obtained by design 8-200, in order to evaluate and quantify how the difference in 
AOx loading affected biosensor performance (Secchi et al., 2013; Rocchitta et al., 
2012). 
 
Table 4 of Section 4.2.1 shows the trend of IMAX values obtained at day 1: the 
increase in Alcohol Oxidase concentration loading from 100 to 200 and 400 units per 
mL led to a linear increase of IMAX values. The highest IMAX values (308 ± 10 nA) 
were obtained with an AOx loading solution of 400 U/mL (design 8-400). After this 
peak, the response exponentially decreased for the more concentrated AOx solutions 
(designs 8-600 and 8-800). 
 
A similar trend was observed for LRS (Table 4). It is surprising to observe a decrease 
in ethanol response for the more concentrated enzyme solutions. This phenomenon 
could be explained by the reduction of the number of active enzyme molecules on 
the biosensor surface.  
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This hypothesis is not consistent with oxygen dependence results: the fact that the 
KM(O2) increased monotonically as the concentration of enzyme in solution 
increased, suggests that the loading of active enzyme is also increasing 
monotonically and producing more H2O2. An alternative explanation is that the 
excessive loading of macromolecules on the surface has decreased the electrodes' 
sensitivity to H2O2 (O’Neill et al, 2008) as confirmed by the hydrogen peroxide 
calibration results showed in Table 5 (Secchi et al., 2013). 
 
Even the presence of PEI and glycerol may affect the response of AOx. As 
previously described, PEI led to an increase in IMAX and LRS on design 8-200 acting 
as enzyme activity enhancer while glycerol gave greater stability to the biosensor 
over time (see also Section 4.1.2 and Rocchitta et al., 2012). The enhancement of 
catalytic activity is related to PEI characteristics: it is a positively-charged molecule 
able to interact with the negative charges of the oxidase enzymes at pH 7.4 
(McMahon et al., 2006). Thus, it is possible that the best combination between 
enzyme loading and PEI enhancement was obtained at immobilizing at design 8 a 
400 U/mL AOx concentration, while a further boost in enzyme loading unbalanced 
this equilibrium (Secchi et al., 2013). 
 
As already discussed, all our efforts were aimed to increase as much as possible IMAX 
and KM values in order to achieve the highest ethanol LRS and linear range (eq. 9). 
As described for design 8-200, the new designs also showed a good linearity up to 40 
mM with R2 > 0.996 (Table 4) because of slight deviations from Michaelis−Menten 
behavior (R2 < 0.984, Table 4) in the form of a flattening of the calibration plot at 
low concentrations (Kirwan et al., 2007; Rothwell et al.; 2010). The only exception 
was design 8-100 that showed a linear response up to 30 mM ethanol (Secchi et al., 
2013). 
 
Design 8-400 showed the best performance, in which LRS value of 3.94 ± 0.12 nA 
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Moreover, data emerged from experiments at day 1 revealed that KM increased 
linearly with enzyme loading up to 400 U/mL, and remaining at stable values for 
higher loads on designs 8-600 and 8-800 (Table 4). This trend reflects both a 
decrease of the affinity of the enzyme to substrate and an increasing difficulty of the 
substrate to access to enzyme catalytic sites (Moral et al., 2005). The above-
discussed enzyme–PEI unbalanced equilibrium and an increase in the number of 
enzyme molecules on the biosensor surface could be responsible of the KM increase. 
This observation is confirmed by the progressive increase of LOD and LOQ values 
with the enzyme loading, as shown in Table 5 of Section 4.2.1 (Secchi et al., 2013). 
 
Finally, no substantial difference among all the new designs at day 1 was found in 
terms of AA rejection (Table 5). As a matter of fact, the 1 mM limiting currents 
ranged from a minimum of 0.98 ± 0.27 nA (400 U/mL) to a maximum of 1.73 ± 0.13 
(200 U/mL).  
The further study of stability of the new biosensors over a period of 28 days showed 
that IMAX and LRS values decreased over time(Figures 26 and 28), while KM slowly 
increased (Figure 27). 
Nevertheless, a significant improvement in terms of stability was shown by design 8-
400; in fact, its better sensitivity and sensibility shown at day 1 (Table 4) was 
confirmed over time, resulting in IMAX and LRS values statistically higher than for 
the others from day 0 to day 7 (p < 0.05 vs other designs), remaining superior until 
day 21. Finally, at day 28, the gap between all designs tended to be smaller, as stated 
in Section 4.2.2. 
 
These results ascertained that a considerable improvement with respect to the 
original design 8-200 was achieved by design 8-400, both at day 1 and over time, 
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Moreover, the biosensors effectiveness to reject AA interference was monitored 
throughout the aging study and expressed as AA ?I, showing an averaged value of 
0.47 ± 0.04 nA (n=20) up to the seventh day after manufacture (Figure 29). Although 
not statistically significant, the increase in enzyme loading progressively improves 
the shielding performance against AA. The above-hypothesized loss of positive 
charges and an increase in negative charges could justify this trend as AA is anionic 
at pH 7.4 (Secchi et al., 2013; Rocchitta et al., 2012). 
 
Unfortunately, after the first week all devices showed an increased sensitivity to AA, 
confirming what was already found for design 8-200: these ethanol biosensors cannot 
be implanted chronically for more than one week because of the decrease in their 
selectivity associated with the increase in AA interference (Sections 4.1.2 and 4.2.2 
and Figure 25). So, the study of enzyme loading assessed that design 8-400 was the 
best performing compared with the original design 8-200 (Secchi et al., 2013), but no 
further improvement in terms of stability over time was achieved.  
To improve AA rejection as well as limit the worsening of PPD polymer over time 
would be a critical requirement for future in-vivo studies, and was therefore the 
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5.4 Ethanol biosensor oxygen dependence  
 
Thus, at this stage of ethanol biosensor optimization, two particular designs showed 
the best performance: design 8-400 and the original design 8-200.  
The next study aimed at selecting what design would be the more reliable for in vivo 
monitoring ethanol concentration variations was to assess the reproducibility of 
biosensors performance under physiological values of oxygen concentration, pH and 
temperature (Secchi et al., 2013). 
As a matter of fact, in vitro working conditions are quite different from those 
biosensors had to face in ECF, mainly in term of air oxygen tension and temperature; 
so it is fundamental to predict which could be the in vivo behavior of biosensors 
exploiting an oxidase enzyme as biological element. 
As discussed before in Sections 1.5.3.2 and 3.4, the flavoprotein Alcohol Oxidase 
uses oxygen as electron acceptor to catalyze the conversion of ethanol into 
acetaldehyde and hydrogen peroxide (Figures 7 and 36, eqs. 6-8). As a consequence, 
an adequate amount of oxygen as co-substrate is required to allow the biosensor to 
reach its highest enzymatic activity.  
A study of the oxygen dependence of biosensors was conducted in PBS in an air-
tight electrochemical cell (See Sections 3.8-3.8.1 and 4.3, Figures 13-16), in order to 
monitor the response of these devices in conditions which simulate striatal oxygen 
concentrations, estimated as about 50 ?M (Zauner et al., 1995; Murr et al., 1994; 
Nair et al., 1987). This value is significantly different from oxygen concentration in 
the air (260 ?M) present in the laboratory environment for in vitro biosensor 
characterization. An oxygen microsensor was used to monitor the variation in O2 
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As shown in Table 6 of Section 4.3, the oxygen-dependence studies showed that 
IMAX(O2) increased with enzyme loading from 100 up to 400 U/mL (64.2 ± 4.3 nA).  
 
The higher IMAX (O2) values were obtained when loading from an AOx solution of 
400 U/mL in design 8-400; after this peak, the response exponentially decreased 
(Secchi et al., 2013). This trend reflects the above-discussed response to ethanol. The 
apparent KM(O2) increased linearly with enzyme loading reaching the value of 72 ± 
11 µM for design 8-800. Dissolved oxygen concentrations in the brain (striatum), 
calculated in a previous study (Bazzu et al., 2009) corresponded to about 37 ?M, a 
value consistent with other results (~50 ?M) from international literature (Zauner et 
al., 1995; Murr et al., 1994; Nair et al., 1987). 
 
Twice the apparent KM(O2) value corresponds to the oxygen concentration in enzyme 
saturation conditions (IMAX(O2)). As a result of this, for monitoring ethanol 
concentrations in the brain ECF independently from oxygen physiological 
oscillations, it is necessary that the implanted biosensor KM(O2) needs to be lower 
than one half of the oxygen concentration dissolved in the brain ECF (i.e., < 25-18 
μM in relation with previous findings). 
In this way, the biosensor would be saturated with oxygen, which is the electron 
acceptor involved in AOx catalysis (see reactions 6–8), so that ethanol oxidation 
kinetics would be limited only by the apparent Michaelis–Menten parameters for 
ethanol.  
 
Unluckily, while design 8-400 demonstrated to be more sensitive and stable up to 1 
week among all designs developed, it displayed an excessive oxygen dependence 
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On the other hand, design 8-100 and design 8-200 fulfill the KM(O2) requirement, as 
illustrated in Table 6. Among these two designs, biosensors loaded with 200 U/mL 
AOx concentration (KM(O2) of 17.3 ± 4.4) was demonstrated here to be the best 
performing in terms of the analytically most important parameter (LRS)
 
on day 1 
(Tables 4-5) as well as of stability over time (Figures 26-29 on Section 4.2.2 ), and 
was therefore considered the most reliable design to monitor ethanol concentration in 
the brain for up to 7 days (Secchi et al., 2013; Rocchitta et al., 2012). 
 
Nevertheless, design 8-400 could be suitable for some in-vivo experiments when the 
concentrations of ethanol are not particularly high as in self-administration 
experiments, where peaks of ethanol are not so pronounced and the consumption of 
oxygen is not pushed to the extreme as it happens for experimental conditions where 
ethanol is administrated i.g. (1 g kg-1). 
Moreover, our result suggested that design 8-400 could be the best biosensor for in-
vitro experiments, in terms of its global performance (Secchi et al., 2013). 
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5.5 Ethanol biosensor response time, pH- and temperature-
dependence 
 
Following the crucial findings derived from oxygen dependence studies, the response 
time for ethanol, and the temperature- and pH-dependence profile of design 8-200 
were investigated, in order to complete its in vitro characterization. 
As discussed in Section 4.4, the response time of ethanol biosensors, corresponding 
to the time needed for the signal to reach 90% of its maximum response value (t90%) 
starting from its baseline current following the addition of ethanol aliquots in the 
electrochemical cell, was quite fast for design 8-200, corresponding to 1.6 ± 0.7 s. 
The pH-dependence results demonstrated that the biological element (AOx) 
exhibited quite a stable response at physiological concentrations of H+ (in the brain) 
in a range between pH 7.36 and 7.42, despite the finding that pH values between 8.6 
and 9.2 resulted in the optimum of biosensor performance (Figure30, Section 4.5), in 
agreement with previous studies (Barsan and Brett, 2008). 
Finally, temperature-dependence studies revealed a fair stability of biosensor 
response at physiological temperatures (Figure 31, Section 4.6). 
As result of the overall findings obtained after biosensor development, 
characterization and optimization, design 8-200 was demonstrated to be the best 
biosensor configuration (among all those studied here) for in-vivo applications up to 
one week after implantation (Secchi et al., 2013; Rocchitta et al., 2012). 
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5.6 Ethanol biosensor in vivo studies  
 
As previously discussed (Section 1.3 and corresponding subheadings), ethanol exerts 
its psychoactive effects by interacting with several neurotransmitter systems, chiefly 
enhancing inhibitory GABAergic transmission and decreasing the glutamatergic 
excitatory systems, while its positive reinforcing properties are related to activation 
of mesocorticolimbic dopaminergic pathways (Di Chiara and Imperato, 1986). 
 
Because the projections of VTA dopaminergic cell bodies play a pivotal role in 
mediating ethanol positive reinforcing properties, and were demonstrated to be 
deeply involved in first stages of alcohol addiction (Sections 1.3.7-1.4), nucleus 
accumbens was chosen as the brain area for real-time monitoring of ethanol 
concentration dynamics (Rocchitta et al., 2012). 
 
Amperometric biosensors (design 8-200) were implanted in the right nucleus 
accumbens of Sprague-Dawley rats by means of stereotaxic surgery performed under 
total anesthesia (see Figures 19-20 in Section 3.11.1 and Rocchitta et al., 2012). 
After the surgery, animals were housed in large plastic bowls, where the in vivo 
experiments were performed at day 1, 24 h after the implant, to allow a full animals’ 
health recovery. 
The telemetric device was connected to implanted biosensors for real-time wireless 
data recording. This arrangement allowed to rats to freely move during the 
experiments, reducing handling and other forms of stress (Calia et al., 2009; Bazzu et 
al., 2009). Biosensors were polarized at +0.7 V vs Ag pseudo RE, and the telemetric 
signal recorded until a stable baseline was obtained (Figures 34 and 36). 
The experiments were carried out using two groups of animals, both administered 
with ethanol i.g. 1 g kg–1. The control group (n=3) was pretreated i.p. with vehicle 
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Figure 36: Representation of in vivo ethanol real-time telemetric monitoring in the brain of 
freely moving rats. 
 
Ranitidine at dose of 30 mg kg–1 dissolved in 1.5 mL of saline was administered i.p. 
to the second group of rats (n = 3), 20 minutes before i.g. administration of ethanol.  
When ethanol reached the brain ECF, there was an increase of its current recorded by 
the biosensors implanted in the nucleus accumbens. Ethanol concentration was 
detected in real-time and estimated using the pre-implantation calibration shown in 
Figure 32 (Rocchitta et al., 2012). 
 
The maximum concentration of ethanol in the extracellular compartment (Figure 34, 
vehicle-treated group), was equivalent to approximately 14 mM (60–80 min) and 
decreased down to ~6 mM (140–160 min). These results, although lower than those 
obtained using in vivo microdialysis by Jamal and collaborators (corresponding to 23 
mM; Jamal et al., 2003), are in agreement with data recorded by Yoshimoto and 
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colleagues, who estimated ECF ethanol at 18 mM under similar conditions 
(Yoshimoto and Komura, 1993). 
In another microdialysis study, Yim and coworkers found a maximum concentration 
of ethanol in the nucleus accumbens corresponding about to 6 mM after i.p. injection 
of 1 g kg–1 of ethanol (Yim et al., 1998). Using proton magnetic resonance 
spectroscopy, Adalsteinsson and collaborators obtained similar results administering 
the same dose of ethanol i.g.; however, the maximum averaged ethanol concentration 
(~30 mM) was reached in the CNS after its i.p. administration (Adalsteinsson et al., 
2006).  
 
These differences in attempts at absolute determination of in vivo ethanol 
concentrations may be related both to different experimental setups and analytical 
methods used for ethanol quantification, and are not surprising in view of the 
assumptions made in these estimations (Chefer et al., 2006). However, the detailed 
real-time concentration dynamics achievable with implanted biosensors, such as 
those shown in Figure 34, are of greater import than absolute levels at this stage of 
in-vivo monitoring methodology development (Rocchitta et al., 2012; Secchi et al., 
2013). 
 
As previously discussed (Sections 1.2.1 and 4.7), ranitidine is a competitive 
histamine H2 receptor antagonist widely used in peptic ulcer disease treatment (Di 
Padova et al., 1992). This drug is also considered to affect ethanol metabolism (Brett, 
2005) by inhibiting cytochrome P450 (CYP2E1), alcohol dehydrogenase (El-Bakary 
et al., 2010) and aldehyde dehydrogenase enzymes (Yokoyama et al., 2001). Because 
of this multitarget pharmacological profile, ranitidine is able to increase the 
bioavailability of ethanol by modifying its pharmacokinetics (see Sections 1.2-1.2.1 
and Arora et al., 2000). 
Evidence has shown that BALs increase in drinkers following ranitidine 
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As Walt and coworkers showed that ranitidine does cross the blood–brain barrier in 
small quantities, estimated as 1–20 ng mL–1 (Walt et al., 1981), we studied the 
effects of the drug on the implantable biosensor in vitro (Figure 33 in Section 4.7) 
before its administration in vivo (Rocchitta et al., 2012).  
Our results showed that ranitidine is not an electroactive molecule, and did not 
interfere with the ethanol signal (Section 4.7). Moreover, biosensor activity was not 
affected by this multitarget drug, demonstrating that alcohol oxidase is not inhibited 
by ranitidine, further justifying its selection as biological element versus alcohol 
dehydrogenase (Section 1.5.3.2). 
 
The administration of ethanol to ranitidine-pretreated animals (n = 3) resulted in an 
increase of extracellular ethanol levels estimated at ~16 mM (60–80 min; Figure 34) 
30 minutes after ethanol administration, quite higher than peak values obtained in the 
saline-control group, although not statistically significant. The subsequent decrease 
in biosensor signal, however, was significantly smaller in the ranitidine-pretreated 
group, estimated as 14 mM versus ~6 mM of saline-control group (140–160 min; p < 
0.05; Figure 34 in Section 4.7), consistent with the inhibition of ethanol metabolism. 
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5.7 Biosensing advantages compared with other ethanol 
detection approaches 
 
The results of the present study ascertained that the developed ethanol biosensor, 
design 8-200, is a reliable device for the short-term monitoring of exogenous ethanol 
in CNS extracellular fluids. The implantable biosensor, integrated into a low-cost 
telemetry system, represents a new generation of analytical tools for studying ethanol 
pharmacokinetics and the effect of drugs on ethanol levels in real time (Secchi et al., 
2013; Rocchitta et al., 2012). 
Moreover, this tool possesses a range of features that makes it more advantageous 
compared with other methods previously used to measure ethanol concentration in 
the brain, such as spectroscopic techniques and microdialysis (Table 10). 
 
As stated above (Section 5.2) and more extended in Section 1.5.1 and corresponding 
sub-headings, clinical and preclinical studies of ethanol kinetics have been carried 
out by means of spectroscopic techniques, exploiting their main advantage, i.e., the 
absolute non-invasiveness of the procedures to monitor changes in ethanol tissues 
concentrations in animal models as well as in humans. These methods used 
spectroscopic techniques such as magnetic resonance spectroscopy (MRS) and 
magnetic resonance imaging (MRI) or positron emission tomography (PET), which 
are principally used to monitor ethanol metabolites (McRobbie et al., 2007; 
Adalsteinsson et al., 2006; Ross and Bluml, 2001; Sammi et al., 2000; Hetherington 
et al., 1999). 
Despite their non-invasive approach which makes spectroscopic techniques reliable 
for in vivo experiments in humans, ethanol cannot be detected in concentrations 
lower than millimolar levels, and only for a short time (a few minutes). Moreover, 
labeled chemicals could be toxic for long-term exposure, and the technique is 
applicable for only non-dynamic experiments in which, even when no tethering is 
required, both animals and humans have to stay motionless during the experimental 




Dott.Ottavio Secchi “Development, characterization and optimization of an implantable 
biosensor for real-time monitoring of ethanol in the brain of freely moving rats” 
Scuola di Dottorato in Scienze Biomediche Indirizzo Neuroscienze -XXVI ciclo 
Università degli Studi di Sassari 
 
In vivo microdialysis (Section 1.5.2, Figure 5) has been applied in preclinical studies 
to investigate the relationship between ethanol-related behaviors and neurochemical 
variations (Gonzales et al., 1998). Furthermore, local perfusion of ethanol in specific 
brain region has been used to investigate the potential involvement of local 
mechanisms, and also to assess the effects of some therapies for alcoholism (Nurmi 
et al., 1994). 
In spite of microdialysis being a well-known and widespread technique due to its 
several advantages, such as the possibility of monitoring ethanol pharmokinetics and 
the concentration dynamics of several neurochemicals at the same time, providing a 
more complete picture of the metabolic changes induced by alcohol intake (e.g., DA 
or 5-HT, see Sections 1.3 and sub-headings), this technique possess some limiting 
factors. For example, it is invasive, because a probe has to be implanted in the brain, 
limiting its use to preclinical studies (Table 10). 
Also, the temporal resolution of microdialysis is poor, and there is a need to have a 
parallel analytical and usually chromatographic system. Moreover, microdialysis 
requires connecting tubes to carry out the experiments, which complicate the 
manipulations of the animals by the operator (Bazzu et al., 2012). This affects the 
stress of the animals and may induce the release of neurotransmitters that are 
collected in the samples, finally influencing (overestimating) the measurement of 
neurochemicals released by ethanol intake. 
 
As shown in Table 10, ethanol biosensors developed in this study have several 
advantages. The main characteristics of these devices are represented by the 
potentially very low invasiveness (e.g., 25-?m diameter PPD-based biosensors have 
been reported; see Rothwell et al., 2009), compared with microdialysis probes, and, 
most of all, the capability of monitoring variations of analytes on sub-second time 
scales. 
As described in Section 3.2 and schematically shown in Figure 7, the length of active 
surface of the biosensors designed here was 1 mm, while its diameter measures only 
125 µm.  
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As a consequence of their small dimension, these miniaturized amperometric 
biosensors are less invasive than microdialysis probes, which have a larger cross-
sectional impact on the tissue (Secchi et al., 2013; Rocchitta et al., 2012; Bazzu et al., 
2012; Bazzu et al., 2011).  
 
 
Table 10: Comparison of characteristics of the different techniques available for monitoring of 
ethanol in the brain  
 
Moreover, by virtue of the electrochemical technique on which the measurement of 
substances is based, biosensors have proved to be a particularly sensitive tool, 
capable of detecting concentrations of ethanol in the order of the micromolar range 
on a very short time-scale. As discussed in Section 4.4, in fact, the response time of 
ethanol biosensors, corresponding to the time needed for the signal to reach 90% of 
its maximum response value (t90%) starting from its baseline current following the 
addition of ethanol aliquots in the electrochemical cell, was quite fast for design 8-
200, corresponding to 1.6 ± 0.7 s. 
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As a rapid detection of ethanol brain level variations is a critical factor to better 
establish and understand the basis of its mechanism of action and its neurobiological 
effects on the CNS, biosensors demonstrated a huge improvement with respect to 
microdialysis and spectroscopic techniques, that require several minutes. 
Also, being these tools associated with a telemetric system during the experiments, 
animals were allowed to be totally free to move, conditions which are not fulfilled by 
spectroscopic approaches and just partially by microdialysis, where a tethered 
detection is required. 
Unfortunately, although minimally invasive, biosensors have not proven to be 
suitable for clinical studies, but could be considered the first more reliable approach 
to monitor the real-time variations of brain ethanol concentrations in animal models 
(Secchi et al., 2013., Rocchitta et al., 2012). 
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5.8 New PPD deposition strategies 
As stated in Section 3.3, a further investigation of polymer deposition strategies was 
conducted in a different experimental environment, carried out in the Biosensors & 
Electrochemistry Laboratory of the School of Chemistry & Chemical Biology at 
University College Dublin. 
The main purpose of this study, performed after the above-discussed ethanol 
biosensor characterization and the in vivo experiments, was to examine the behavior 
and the efficiency of the PPD polymer when the ortho-phenylenediamine monomer 
(weak base electrolyte) was dissolved in media other than PBS, which had been used 
up to this point in our laboratory in Sassari (Section 3.2), in order to improve the 
shielding efficiency to AA and other electroactive species, as well as to reduce the 
effects of aging on biosensor functionality (Sections 4.1.2 and 4.2.2 and Figure 25). 
 
The effectiveness of novel polymer layers was assessed by comparing both 
electropolymerization and AA-calibration parameter values (such as Q(poly), 
t½(poly), Imax(AA), tmax(AA) and IL(AA)), and the apparent permeability and 
selectivity parameters P(HP)%, P(AA)% and S% (see eqs 3–5 in Section 3.3 for a 
detailed explanation of these parameters). These last three parameters were 
considered the main discriminative values to evaluate the analytical performance of 
the different polymers studied.  
As a matter of fact, permeability and selectivity parameters define the capacity of the 
various non-conducting polymers to allow H2O2 (the biosensor signal transduction 
molecule) through while inhibiting the flux of the electroactive interference molecule 
AA to the electrode surface (see Tables 8-9 in Section 4.8 and Lowry and O’Neill, 
1994; Centonze et al., 1994).  
 
Background electrolyte solutions differing from the commonly used deoxygenated 
PBS were tested, dissolving oPD monomer in MilliQ water and HCl (10 and100 mM 
in water). Furthermore, once the best medium was found, different oPD 
concentrations (50 and 100 mM) were investigated. 
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Values obtained for the new polymers were compared with those from the classic 
medium commonly used for the polymer coating electrosynthesis, i.e., by dissolving 
300 mM oPD in PBS buffer (pH 7.58, conductivity equal to 12.9 mS cm−1 see Table 
7).  
 
Sensors coated with this classic method showed the best results in terms of Imax(AA), 
equal to 1.1 ± 0.1 nA (n=12), but reached after  quite a long time course, tmax(AA) 
value (66 ± 9 min). Nevertheless, this polymer guaranteed a good IL(AA) value, 
corresponding to 0.58 ± 0.09, as shown in Table 8. 
 
The reference PBS conditions of deposition resulted in an apparent permeability to 
hydrogen peroxide, P(HP)%, corresponding to 72 ± 11% (n=12) and in an excellent 
AA-rejection (P(AA)%) value of 0.15 ± 0.03% (Table 9). 
The S% value, indicating polymer selectivity, and defined by eq 5 (Section 3.3), 
represents the percentage interference by AA in H2O2 detection for equimolar 
concentrations, was estimated 0.17 ± 0.03%. 
 
Among all the new polymers tested, an improvement in hydrogen peroxide 
permeability was achieved by polymerizing the platinum wires with a 100 mM 
HCl+300 mM oPD solution (93 ± 5%; n=12, Table 9 in Section 4.8). This indicates 
that the difference in the slopes (nA mM-1) obtained for the hydrogen peroxide 
calibration performed before and after the polymer deposition was really marginal.  
Unluckily, this improvement was not combined with better AA-rejection values 
related with PBS conditions. In fact, P(AA)% value was 0.82 ± 0.02 %, and S% 
corresponded to 0.36 ± 0.02 % (n=12, Table 9). Moreover, the polymer made by 
deposition in 100 mM HCl+300 mM oPD resulted in the worst Imax(AA) value and 
longest tmax(AA) values. 
 
A higher P(HP)% value relative  to the PBS reference condition was also reached by 
polymerizing the sensors using a 10 mM HCl+300 mM solution, corresponding to 81 
± 4% (n=16). In this case, however, these new electropolymerization conditions also 
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led to the best AA shielding efficacy, showing an excellent P(AA)% value of 0.09 ± 
0.02% (n=16), almost halving the one obtained from the common PBS condition. 
The higher P(HP)% value together with the best AA rejection also resulted in the 
best polymer selectivity (S%): the percentage interference by AA in H2O2 detection 
for equimolar concentrations for biosensor applications would be ideally zero. By 
polymerizing the sensors using a 10 mM HCl+300 mM solution, S% was as low as 
0.07 ± 0.02% (n=16, see Table 9 in Section 4.8). 
So, even if this polymer showed the highest Imax(AA) value (4.0 ± 0.5 nA, n=16) 
compared with PBS, the peak was reached in a shorter time (tmax(AA) = 34 ± 2 min, 
n=16), soon decreasing and stabilizing its 0.5 mM AA limiting current at lower 
values (data not shown). 
 
The same concentration of oPD monomer was also dissolved in MilliQ Water. The 
electropolymerization of the sensors performed in this medium yielded an Imax(AA) 
value of 6.0 ± 0.3 nA (n=16) in a time tmax(AA) of 65 ± 8 min, while the AA limiting 
current (IL(AA)) value was 0.69 ± 0.22 nA (n=16), as shown in Table 8. 
This polymer showed the worst hydrogen peroxide permeability (P(HP)% value of 
46 ± 7%, n=16), and a high P(AA)% (0.55 ± 0.8%), resulting in the worst selectivity 
among all the polymer investigated (S% value of 0.74 ± 0.8%, see Table 9 of Section 
4.8). 
 
Once determined that the best performing polymer to this point was obtained by 300 
mM solution in the 10 mM HCl aqueous medium, our study investigated what may 
be the effect of dissolving a lower concentration of oPD on polymer permselectivity. 
 
Thus, two new polymers were obtained, electrodepositing the polymer with 10 mM 
HCl+100 mM oPD and 10 mM HCl+50 mM oPD solutions. These polymers gave 
essentially the same results in terms of Imax(AA) value compared with 300 mM oPD, 
but showed a drastic worsening of tmax(AA) values, and AA limiting currents, found 
to be higher of a factor of six (Table 8). 
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Moreover, they showed a lower P(HP)% value and poorer (higher) values of 
P(AA)% and S%. 
So, by virtue of the good hydrogen peroxide permeability (81 ± 4%) and the 
excellent AA rejection properties (P(AA)%, 0.09 ± 0.02%), the polymer obtained by 
polymerizing at +0.7 V vs the pseudo Ag reference electrode (± 20 mV vs SCE) in 
the 300 mM oPD monomer dissolved 10 mM HCl solution resulted in the best 
selectivity value (S%, 0.07 ± 0.02%, n=16). Surprisingly, wide variations in PPD 
electrosynthesis conditions only marginally affected the ability of this polymer to 
transport H2O2 to the metal surface, while demonstrating an efficient AA interference 
rejection. For example, even a three orders of magnitude difference in the half-life of 
the electropolymerization self-sealing process observed between the pure water and 
PBS systems (Table 8), only gave rise to a factor of four difference in their resulting 
permselectivity (S%) values. Thus, the correspondent value of S% obtained by 
dissolving the monomer in PBS buffer was 0.17 ± 0.03% (n=12). This result revealed 
that the novel polymer improved the permselectivity by a factor of 2.4. 
 
The above-cited new PPD electropolymerization conditions were tested in 
experiments done after the in vivo work. As a consequence, the stability of the new 
well-performing 10 mM HCl PPD polymer would have to be determined before its 
benefits could be exploited for future neurochemical monitoring studies. 
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5.9 Future biosensor outlooks 
 
If benefits of the new well-performing 10 mM HCl PPD polymer, discussed in 
Section 5.8, will be confirmed in terms of AA shielding efficency for a time longer 
than the current limit of 7 days (see Sections 4.1.2 and 4.2.2 and Figure 25), it would 
be possible to extend the reliability of biosensor in vivo use, and enlarge the field of 
application of this tool also to ethanol self-administration experiments (Loos et al., 
2013; June and Gilpin, 2010), where protocols could require a long-term monitoring 
of ethanol ECF concentration (Secchi et al., 2013; Rocchitta et al., 2012). 
Moreover, the contemporary implantation of other sensors could be achievable in 
specific brain areas, to detect those neurotransmitters particularly involved in ethanol 
psychotropic and reinforcing effects, such as glutamate (see Section 1.3.2 and 
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In the present thesis, the development, characterization and optimization of an 
amperometric biosensor for real-time monitoring of ethanol is described.  
 
The detection of ethanol concentration dynamics in the brain kindles a particular 
interest, due to the fact that alcohol is the most widely-used psychoactive drug whose 
unregulated use can lead to toxic actions on peripheral organs (chiefly the liver) and 
CNS, as well as to the development of a severe progressive disease, namely 
alcoholism. 
Alcohol addiction produces physiological changes in the brain in which 
neurotransmitter systems are disrupted and deeply altered, generating adaptive 
processes resulting in a compensatory balance. The changes involve the main CNS 
neurotransmitter systems, such as GABA, glutamate, serotonin, opioids and other 
neuronal systems (also affected by acute ethanol exposure) that concur to develop 
neuroadaptive phenomena, such as sensitization, tolerance and psychophysical 
dependence, in which the mesocorticolimbic dopaminergic system plays the pivotal 
role. 
 
Several scientific papers cited, discuss ethanol pharmacokinetics and concentrations 
in the brain of both humans and animals. In fact, a wide range of studies aimed at 
understanding the complicated basis of ethanol mechanism of action and interactions, 
using different approaches such as microdialysis and spectroscopic techniques, have 
been reported. Nevertheless, the above-cited techniques showed weakness and 
limiting factors that affected their reliability for ethanol detection, mainly related to 
temporal limitation. Because ethanol concentration in the brain can vary 
dynamically, as well as those of the neurotransmitters it affects, its optimal study 
would require a real-time approach. 
 
Thus, the aim of the present study was to develop and characterize an implantable 
amperometric biosensor capable of real-time recording of ethanol concentration 
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This miniaturized tool (diameter of 125 µm) exploits the biological element AOx, an 
oxidoreductase enzyme, to selectively oxidize the ethanol, by producing hydrogen 
peroxide as by-product, which is further oxidized at the surface of a Pt wire 
transducer by applying a constant potential between the biosensor (working 
electrode) and the reference electrode, giving an electrical response (current) directly 
related to the analyte (ethanol) concentration. 
 
Ten different designs were initially manufactured, all based on the same approach to 
reject electroactive interference molecules, i.e., the electrodeposition of a nanometer 
thick PPD polymer. Moreover, AOx was loaded in all these initial designs by dipping 
the biosensors in a 200 U/mL enzymatic solution.  
Then, the effect of PEI, Glyc or the combination of both these enzyme stabilizers on 
AOx performance was investigated, as well as the deposition of two different kinds 
of “trapping nets”, specifically PU and BSA-GA. 
 
Biosensors were characterized in vitro in an electrochemical cell in terms of apparent 
Michaelis–Menten kinetic parameters (IMAX and KM), sensitivity in the LRS, LOD 
and LOQ parameters, as well as in their efficiency to shield electroactive interference 
species, especially AA.  
These parameters were used to compare biosensors performance from the day of 
their manufacture over a time of 28 days (aging biosensor study), in order to quantify 
their stability and ascertain the most reliable design for in vivo use. 
 
Biosensor characterization determined that design 8 was the best performing and 
stable biosensor among all those developed, reliable for in vivo ethanol monitoring 
up to 7 days. Having established the benefits of this design, its multilayered 
configuration was not varied, nor was the deposition sequence, while it was used as a 
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Thus, our study re-focused on investigating what the effects may be of depositing a 
different concentration of the enzyme AOx on biosensors performance, compared to 
the 200 U/mL solution used until this stage of the project and demonstrated to be 
successful in design 8, renamed as design 8-200. Hence, the only variable considered 
to further optimize the biosensor was to change the AOx solution concentration.  
 
Four new biosensor designs were obtained, using 100, 400, 600 and 800 U/mL AOx 
solution concentrations, and characterized for the same parameters of ethanol 
sensitivity and efficiency of AA shielding, both at day 1 and over 28 days. Data 
obtained were then compared with those from design 8-200, carried out in the same 
experimental conditions. 
 
Biosensors loaded with 400 U/mL of AOx, named design 8-400, improved the 
performance of the original design 8-200, doubling its IMAX and LRS values up to the 
seventh day after their manufacture. 
 
After that, the oxygen dependence of the biosensors was studied, due to the fact that 
in vitro working conditions of oxygen tension (260 µM) are quite different from 
those biosensors would have to face in ECF of the brain, where oxygen concentration 
was estimated as ~50 µM, and it is fundamental to predict which could be the in vivo 
behavior of biosensors exploiting an oxidase enzyme as biological element. 
Specifically, it is necessary that the implanted biosensor KM(O2) needs to be lower 
than one half of the oxygen concentration dissolved in the brain ECF (i.e., < 25-18 
μM). 
Unluckily, design 8-400, the best performing design developed until this stage, 
displayed an excessive oxygen dependence which could undermine its in vivo 
performance. On the other hand, the original design 8-200 fulfilled the KM(O2) 
requirement, and was therefore considered the most reliable design to monitor 
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The biosensor response time, and pH- and temperature-dependence studies 
successfully completed the in vitro characterization of design 8-200. 
 
Then, these biosensors were implanted by means of stereotaxic surgery in the 
nucleus accumbens of male Sprague-Dawley rats. The coupling with a previously-
developed telemetric device allowed the performing of the first real-time monitoring 
of ethanol in the brain of freely moving rats, administered i.g. at the dose of 1 g kg–1 
to two groups of rodents, either alone or in combination with ranitidine, an inhibitor 
of enzymes metabolizing alcohol.  
The implanted biosensor was demonstrated to be a reliable device for the short-time 
monitoring of exogenous ethanol in brain ECF, and represents a new generation of 
analytical tools for studying ethanol toxicokinetics and the effect of drugs on brain 
ethanol levels. 
 
Moreover, several strategies were tested in order to find the best PPD polymer to 
shield the interference due to electroactive molecules present in brain ECF, mainly 
represented by AA, as to extend the temporal limit of a reliable LIVE monitoring. 
 
In this way it would be possible to enlarge the field of application of this tool also to 
ethanol self-administration experiments, were protocols could require the continuous 
monitoring of ethanol ECF concentration for a time longer than 7 days. 
Moreover, the co-implantation of other sensors in specific brain areas could be very 
interesting to detect neurotransmitters, chiefly dopamine, particularly involved in 
ethanol psychotropic and reinforcing effects of ethanol, and that play a critical role in 
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